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ABSTRACT 
 Liquid chromatography-mass spectrometry (LC/MS) is a robust and sensitive 
technique used for the separation, identification, and quantification of small molecules 
within a mixed biological sample. It is commonly used in metabolomic analyses, which 
complement genomic, transcriptomic, and proteomic data when investigating complex 
systems. LC/MS is the gold standard for resolving metabolites and end-products, but 
the results obtained from LC/MS are not necessarily standardized and reproducible; 
individual LC/MS protocols must be fine-tuned for every laboratory and for every unique 
experiment. Depending on the research question being asked, LC/MS can be used in 
an untargeted strategy to investigate relative metabolite shifts and discover new 
biomarkers or a targeted strategy for quantitative analyses of one or a few metabolites.    
Because of its broad range of applications, LC/MS protocols can be created to 
support a number of different studies that are investigating seemingly unrelated areas of 
science. In one study, we quantified the levels of a neonicotinoid, imidacloprid (IMI), in 
pig urine using a spike of internal standard D4-Imidacloprid (D4-IMI) at known 
concentration. The urine samples were prepared using a modified solid phase 
extraction (SPE). This experiment is an example of a targeted LC/MS approach since 
we achieved precise quantification of trace amount of imidacloprid within 6 urine 
samples.  The LC/MS protocol we developed also included tandem MS/MS and multiple 
reaction monitoring (MRM) mode that created specific channels to monitor previously 
identified daughter ions of IMI and the internal standard D4-IMI.  
 The subsequent LC/MS utilization first required purification of 5α-cyprinol sulfate, 
the main bile alcohol present in both carp and zebrafish, which is not available for 
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commercial purchase. Crude carp bile was purified using thin layer chromatography and 
flash column chromatography. The identity of the major bile alcohol, 5α-cyprinol sulfate, 
was determined by mass spectrometry (MS) and nuclear magnetic resonance (NMR) 
spectroscopy. The purified 5α-cyprinol sulfate was used as an LC/MS standard to 
investigate bile composition in carp and zebrafish. 5α-cyprinol sulfate was also used as 
a substrate to investigate metabolism by bacterial cultures of zebrafish intestinal 
communities. After SPE, the cultures were injected on to LC/MS in an untargeted 
approach to identify potential bile metabolites.    
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CHAPTER 1: Literature Review 
 
INTRODUCTION TO METABOLOMICS 
 
Metabolomics is a powerful addition to the high-throughput “omics” revolution.1,2 
It is defined as the identification, quantification, and study of metabolic end-products in 
relation to a whole system or levels of a system.1 Metabolomics joins genomics, 
transcriptomics, and proteomics to assess the global screening of biomolecules within a 
system, leading to investigations between relationships at different genetic levels within 
the system.3 In fact, metabolomics data represents the final phenotypic markers for all 
of the above “omics” measures. That feature allows new mechanistic discoveries to be 
made by working backwards, thus providing clues to the upstream relationships 
between all other “omics” categories.1 In other words, metabolomics can unveil links 
between host genotype and phenotype, which may have previously been undisclosed 
by studying genomics, transcriptomics, and proteomics alone.4 The onset of 
metabolomics has been fueled by recent technological advances, namely mass 
spectrometry and chromatography techniques.5 However, the overall usefulness of 
metabolomic techniques are limited by the standardized metabolite libraries currently 
available and the reproducibility of various instrument protocols.4 Nevertheless, 
metabolomic approaches are frequently used in research to characterize phenotypes 
and identify end products,4,6 and those robust techniques will continue to enhance basic 
science.1 Here, we develop several methods used to identify and quantify end products 
using modern metabolomic strategies. These findings support the work of two very 
different studies, which both bridge the gap between host physiology and their 
respective end products or metabolites.    
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CHARACTERISTICS OF METABOLOMICS 
 Studying global systems biology is complicated, however, breaking the entire 
system down to focus on a subset of characteristics can untangle the daunting process. 
That is exactly what the “omics” strategies, including genomics, transcriptomics, and 
proteomics, aim to do.1 Genomics is the study of all of the DNA within a system (host, 
microbe, etc.).7 Not all genomic DNA encodes an expressed gene within the system, 
which is why transcriptomics is used to examine the DNA regions that are actually 
transcribed into mRNA.8 Furthermore, proteomics approaches are utilized to 
quantitatively examine which mRNA transcripts are translated to active proteins, which 
may later be regulated further by post-translational modifications as well as protein-
protein interactions.8 These genes, transcripts, and proteins may be unstable in vitro 
environments, but they all function together in biochemical pathways to produce various 
end-products: metabolites.3 Metabolomics encompasses the collection of small 
molecules produced by various cells.1 It is data-driven, and viewed as the most direct, 
unbiased measure of a system’s phenotype.4  
 Metabolomics can also be referred to as metabolite profiling, metabolic 
fingerprinting, or metabolic phenotyping, among other titles.3 It is the newest addition to 
the “omics” family described above.2 The number of publications including 
metabolomics and metabolite profiling has grown exponentially since 2001, despite that 
it was first mentioned in the literature in the 1950s.2 This revolution is driven by 
technology as well as interest in complex systems such as the microbiome, for 
example.7 Early metabolomic analysis came from Donald Nicholson, who drew out 400 
metabolites from approximately 20 biochemical pathways by hand in his book that was 
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published in 1970.9 At that time, metabolite discovery was performed using analytical 
chemistry.10 The core analytical chemistry approaches used in metabolomic 
investigations remain the same, although the technology used has drastically changed.9   
Modern metabolomic strategies are only as powerful as the ability to analyze 
large datasets.4 A workflow of metabolomic analysis from beginning to end generally 
includes sample preparation, data acquisition, data processing, data pretreatment, data 
analysis, pathway analysis, and biological interpretation.3 In other “omics” analysis, 
coding sequences such as nucleotides and amino acids can be interpreted and 
quantified in order to draw conclusions.3 This is not the case with metabolomics, and 
strategies independent of sequencing are necessary for data collection. The high-
throughput instrumentation used to acquire these data include variations of nuclear 
magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), which are often 
coupled with chromatography features.2,3,8 
RESOLUTION TECHNIQUES 
 
Nuclear Magnetic Resonance: Nuclear magnetic resonance (NMR) is the 
analysis of local magnetic fields around atomic nuclei. By using a magnetic field on 
charged nuclei, an energetic spin is detected that corresponds to a specific frequency. 
The frequencies are analyzed as chemical shifts which provide atomic information and 
are used to infer molecular functional groups.11 Several types of NMR analyses exist 
with the most common being 1H, 13C, 15N, and 31P. In this review, 1H and 13C NMR 
scans will be discussed, whereas 15N is commonly used for NMR of proteins and 31P is 
frequently used for in vivo cellular energy monitoring.12 One-dimensional NMR analyses 
are used to count the number of respective atoms within that molecule, and they 
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provide the measured spectra on the x axis with frequency on the y axis.3 The 1H 
spectra is the most frequently used in NMR analysis due to its high sensitivity, although 
there can be ambiguity in metabolite identification since the metabolite signals can be 
interpreted in more ways than one.2,3,12 Two-dimensional frequency analyses are used 
to interpret a molecule’s unique stereochemistry, and they include combinations of 
frequency spectra on the x and y axes, including 1H-1H COSY (correlated 
spectroscopy), 1H-1H TOCSY (total correlation spectroscopy), and 1H-13C HSQC 
(heteronucleur single-quantum correlation). Unlike one-dimensional NMR data sets, 
two-dimensional data sets are unambiguous. Software programs are available to solve 
COSY and HSQC data, and the signals in these datasets do not overlap to generate 
false positives.12  
NMR is one of the most frequently used strategies for metabolite identification.2 It 
is popular because NMR data can be obtained relatively quickly, and it is non-
destructive to the sample being analyzed.12 NMR is commonly used to determine 
structures of unknown compounds, and it is often considered the gold standard for 
structural analysis.3,12 NMR can resolve compounds that may be difficult to visualize in 
other metabolomics techniques, and it can unambiguously distinguish differences 
between isomeric compounds with identical masses.12 NMR analysis can be used for 
quantification purposes as well as coupled to MS for enhanced metabolite 
identification.12  
However, there are some drawbacks to NMR use in metabolomics. While some 
biological samples do not need much preparation for analysis, certain sample types 
containing large proteins (urine, plasma, etc.) often require additional treatment to avoid 
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protein signals from interfering with metabolite interpretation.2,12 Typically, NMR is 
capable of micromolar-level sensitivity,3 meaning NMR technology is less sensitive than 
other approaches, such as gas and liquid chromatography, that will be discussed later.12 
Low instrument sensitivity suggests that a large quantity of sample may be needed for 
high resolution data, and this is not always possible. The low sensitivity of NMR is 
considered its greatest hindrance.12 To achieve greater sample sensitivity relative to 
NMR, mass spectrometry (MS) is commonly utilized.  
Mass Spectrometry: MS is the identification of substances using their molecular 
mass and ionic charge. The sample of interest is exposed to an ion source in order to 
make gas-phase ions. The most common ionization method used in MS is electrospray 
ionization (ESI).13 Electrospray ionization is the formation of gas-phase molecules from 
a liquid or solid substance.14 It is performed in either cationic (positive) or anionic 
(negative) mode, meaning that the substance being analyzed will display its native 
mass plus or minus one hydrogen ion, respectively.14 The resulting ions are sorted and 
detected in the form of a mass-to-charge ratio (m/z).14 The m/z ratio is the value on the 
x axis of MS data. It is a dimensionless quantity that is equal to the mass ion number 
divided by its charge number.14 A mass analyzer instrument is needed to scan the 
ionized sample and provide a data output. The Quadropole time of flight (QTOF) MS is 
frequently used due to its capabilities to determine an ion’s m/z rather quickly, allowing 
for rapid data output.13 The MSE technique uses the QTOF to alternate between high 
and low energy scans, and it has the ability to accurately cover a range of metabolites 
within a sample using one-dimensional parent ions or two-dimensional daughter ions.3 
Tandem mass spectrometry (MS/MS) utilizes two mass analyzers to determine m/z data 
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for daughter ions. After the first mass analyzer detects intact gas-phase ions (parent 
ion), those ions are fragmented in a collision cell, based upon a collision energy specific 
to the compound. The second mass analyzer detects those fragments (daughter ions) 
to produce a data ouput with a single, unique mass.3 Tandem MS/MS provides more 
sensitive data than singular MS, and it is preferred for quantification of analytes 
because the parent/daughter ion set is unique to individual analytes even if the parent 
ion mass is the same. Single reaction monitoring (SRM) and multiple reaction 
monitoring (MRM) provide the most sensitive MS data but require a pre-defined m/z of 
interest. For SRM and MRM, only parent ions within the selected m/z range experience 
fragmentation. This MS method is most accurate for trace compound detection because 
the mass analyzer is specifically targeted to the desired m/z.3 
Mass spectrometry is useful in metabolomic investigations for several reasons. 
The MS protocol is a quick automated process in which complex samples can often be 
analyzed in under 5 min.8 It is an accurate and sensitive technology, meaning that trace 
masses can be detected.3 The limit of detection for MS is at the nanomolar or picomolar 
concentrations depending on the instrumentation and method.15 A sample does not 
require purification or separation to be analyzed on MS, although this is often helpful.3 
The height/intensity of MS peaks can be used for quantification estimation relative to an 
internal standard at known concentration,14 but separation techniques are often coupled 
to chromatography for accurate quantification.8 
 MS is a necessary part of metabolite identification, but the utilization of m/z data 
has limitations. MS is a destructive method, and samples cannot be recovered after 
use.3 There is potential for mass discrimination due to variations in ESI efficiency and 
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mass analyzer efficiency against all compounds within a biological sample.14 Ion 
suppression can occur if one species interferes with ionization of another species in a 
sample containing various compounds. While mass analyzers are highly sensitive, they 
still cannot distinguish between isomeric compounds with identical masses.8 In order to 
separate various compounds based on their chemical properties, an additional 
chromatography dimension is often coupled to MS analyses.8  
Chromatography: Chromatography is a broad term that refers to the separation of 
mixed biomolecules.5 It is a basic analytical chemistry application which is rooted in thin 
layer chromatography (TLC) techniques.16 TLC was first described in the literature in the 
late 1930s, and it’s separation capacity is based on various phase interactions.16 The 
solid phase component consists of an adsorbent material (silica gel, alumina, cellulose) 
on a glass plate. A mixed sample suspended in organic solvent is placed on the bottom 
of the plate, and it is allowed to come into contact with a liquid mobile phase, which 
moves up the plate using capillary action. The mixed sample interacts with the mobile 
phase and migrates up the plate.5 The compounds within the sample ideally have 
differential migration rates, which are used to calculate retention values, or Rf values.17 
Rf values are calculated as the distance the center of the visualized compound has 
migrated divided by the distance the solvent has migrated up the solvent front. Rf values 
differ based upon the compound’s polarity as well as the interactions with the chosen 
solid and mobile phase. Rf values between samples and standards can be compared, 
but these comparisons are ambiguous and are not generally used to confirm metabolite 
identity.17 While Rf values can be used for qualitative purposes, they are inappropriate 
for modern investigations requiring metabolite mass data and/or quantification.16  
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Contemporary chromatography includes many different variations to separate a 
plethora of molecules based upon a specific feature. Chromatography techniques can 
be used to separate chemical metabolites, proteins, or nucleic acids based on 
molecular characteristics such as hydrophobicity, ionization, and size.5 For example, 
flash column chromatography is used to separate molecules within a mixed sample 
based on their polarities.5 The sample is loaded on top of silica gel packed in a tall 
column, and metabolites are eluted using a gradient of organic solvents. The 
metabolites are “released” from silica due to their unique hydrophobic interactions with 
the changing mobile phase.5 While the types of molecular interactions differ, the three 
main components of chromatography remain the same: a separation mixture, a solid 
phase, and a mobile phase.5 Modern mobile phase options include both gas phases 
(gas chromatography) and liquid phases (liquid chromatography), which both have 
unique features that allow for accurate separation chromatography. In order to 
characterize and identify the separated compounds, these chromatography techniques 
are combined with MS analyzers. Thus, the coupled separation techniques are referred 
to as gas chromatography mass spectrometry (GC/MS) and liquid chromatography 
mass spectrometry (LC/MS).2 
  Gas Chromatography: Metabolite analysis using GC/MS is widely used and was 
performed before LC/MS techniques.8 In 2004, Weckwerth et al.18 demonstrated the 
power of GC/MS metabolomic investigation in plants. This work was able to resolve 652 
metabolites on a single leaf sample using GC/MS. When deciding to use GC/MS, the 
gas mobile phase must be considered. Inert helium and nitrogen gases are generally 
used as the carrier gases in sample analysis.5 A non-polar mobile phase (helium) allows 
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for separation of metabolites based on their boiling point. A polar mobile phase 
(nitrogen) will separate metabolites based upon their polarities.8 The GC/MS stationary 
phase is located within a capillary column which also contains a stationary liquid phase. 
Sometimes, the combination of mobile phase with one column alone is inadequate to 
separate all metabolites in a mixed sample. Therefore, a sample may be separated 
using two columns which is called two-dimensional GC (GC x GC). This method 
becomes GC x GC/MS when it is coupled again with a MS analyzer. As studies aim to 
examine metabolites in complex samples such as urines, GC x GC/MS techniques are 
being utilized more frequently.8  
 Gas chromatography technology has high metabolite resolving potential. There 
are other benefits to choosing GC analysis since it is a sensitive method that does not 
require a large sample quantity,5 and it is an affordable option for sample analysis.9 The 
results obtained from GC/MS are reproducible since inherent metabolite properties such 
as boiling point and polarity are relatively stable. Plus, sample variations due to 
instrumentation conditions is low, even between multiple vendors.3,8 The reproducibility 
aspect of GC/MS has allowed for creation of universal databases based upon 
metabolite profiles.4 Overall, GC/MS techniques are reliable methods of metabolite 
separation and identification.  
The GC technology described is frequently used to identify various lipid, long chain 
alcohols, amides, alkaloids, sugar alcohol, and organic acids, although it is destructive 
to these molecules within samples.3 While this is a seemingly wide range of resolved 
compounds, GC/MS is not free from high rates of metabolite bias. In order to detect 
metabolites using GC/MS, the metabolite itself must be both thermally stable and 
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volatile. If the metabolite is not already volatile, then it often needs to go through a 
chemical derivatization step that can add time to sample preparation as well as add 
additional sample variance.3,8 For this reason, some investigators avoid GC/MS and opt 
for a liquid chromatography (LC) separation technique. An LC/MS protocol can be used 
to separate biological mixtures with potentially less sample preparation and less 
metabolite bias than GC/MS.8 
Liquid Chromatography: The usefulness of gas chromatography led to the 
development of LC13, which is often considered the technique of choice for separation of 
biomolecules.8,13 Separation is achieved by using high-performance LC (HPLC) at 
approximately 6,000 psi or ultra-high performance LC (UHPLC) at approximately 15,000 
psi, with the latter having greater resolution potential and metabolite coverage.3,13 These 
analyses are usually coupled with an MS analyzer, thus resulting in liquid 
chromatography mass spectrometry (LC/MS).2 The advanced separation of LC/MS is 
achieved partially from the stationary phase column used.  If the stationary phase 
column is polar and the liquid mobile phase is non-polar, the method is referred to as 
normal-phase liquid chromatography. If the stationary phase is non-polar combined with 
a polar liquid phase, then the method is termed reversed-phase chromatography. 
Reversed-phase columns contains hydrophobic, non-polar stationary phases such as 
C8 and C18, and these are used in about 75% of all LC methods because of their superior 
metabolite coverage.3,13 When using reversed-phase column chromatography, polar 
hydrophilic molecules (such as salts and alcohols) will be eluted first before hydrophobic 
molecules. Like many other metabolomic techniques, LC/MS can also be performed in 
tandem. Two-dimensional LC analysis utilizes two solid phase columns to achieve 
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enhanced separation of various metabolites in a sample. Often, specific fractions are 
retained in the first LC protocol that separates based on ion exchange characteristics 
and then transferred to the second protocol which uses a reversed-phase column to 
separate again based on polarity.19  
 LC is often considered the most sensitive, versatile technique for metabolite 
separation. It has the most robust metabolite coverage of other techniques, including 
GC/MS.9 For this reason, it is commonly used in forensics to identify trace compounds 
in complex biological samples.20 LC/MS is frequently used to separate steroids, amino 
acids, proteins, lipids, and carbohydrates.5 It operates at a lower temperature than 
GC/MS and does not specifically require sample derivatization.3 LC/MS is nearly fully 
automated and can be performed rapidly, with some instruments having the potential to 
process 100 samples per day.1 
 The greatest limitation of LC/MS concerns data interpretation and 
reproducibility.9 LC/MS instruments have high variability, and protocols are sensitive to 
slight changes such as temperature, mobile phase/sample pH, and column condition.4 
In order to compare a set of samples, they often have to be run simultaneously, using 
the same LC protocol, on the same day. This also suggests that the retention times of 
various metabolites cannot always be directly compared,3 which makes generation of 
universal metabolite libraries for LC/MS very difficult to achieve.9 The lack of obtainable 
metabolite standards is another limiting factor to the reproducibility of LC/MS.4 To obtain 
the best LC/MS experimental results, it is best to construct an LC/MS standard 
metabolite library using in-house instruments and protocols.  However, this is a timely 
endeavor and sample variability cannot be completely eliminated.8           
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DATA PROCESSING APPROACHES 
Quantification of Metabolites: Both GC/MS and LC/MS are high-throughput 
technologies valuable to metabolomics research due to their sensitivity and potential to 
provide biological clues useful for untangling complex biological systems.9 Another 
benefit of both techniques is their ability to quantify metabolites.4 For quantification 
experiments, full metabolite profiles are generally obtained from LC/MS data since this 
chromatography strategy has the best coverage and least sample bias.9 As discussed 
earlier, chromatography is used to separate complex biological samples that result in a 
retention time measured in min on the x axis. LC detectors set to a specific wavelength, 
for example, can be used to select for certain chemical compounds, although this is not 
necessary.21 After ionization, a mass analyzer sorts the ions into a mass detector, which 
provides data representing the compounds’ molecular weight and charge in a m/z ratio. 
Thus, each compound within that mixed sample will correspond to a unique retention 
time and m/z, which will be represented in a peak on a chromatograph, with the relative 
abundance of that peak being on the y axis.4 The area under the curve of each 
metabolite peak can be determined by data analysis software, and it is directly related 
to metabolite abundance within that sample.22 This LC/MS feature is crucial to the 
following section on data processing approaches. The peak areas obtained from 
chromatograph data analysis can be compared relative to other peak areas in an 
untargeted data processing strategy.4 Alternatively, the peak areas can be precisely 
quantified in reference to a spiked internal standard of known concentration in a 
targeted data processing strategy.22 Often, these two approaches complement one 
another in metabolite discovery and abundance studies.22 
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Untargeted Approach: Metabolomics can be considered the most powerful of 
the “omics” sciences due to its conclusive global approach, partially achieved by 
untargeted strategies.8 Using an untargeted metabolite separation approach, one can 
obtain an unbiased global peak spectra of the present small molecules in a system. The 
goal is to resolve as many peaks as possible with a unique retention time and m/z 
value.23 Theoretically, these metabolite features would allow for the identification of 
every small molecule and metabolite in that sample. However, seeking to identify every 
peak in a system is often unreasonable since there are countless possible small 
molecule metabolites produced by cells.1 As mentioned before, this would require 
previous knowledge of the sample composition and/or a robust database.8 With that in 
mind, the peaks in an untargeted approach most likely correspond to an unknown 
compound or metabolite, making it inefficient to examine every peak in detail.1,9 Instead, 
the untargeted approach is generally used to study relative abundances of peaks 
without prior identification.4 This can later lead to the discovery of biomarkers and other 
metabolites of interest.10 
Untargeted approaches to metabolomic questions allow for relative comparison 
between the resulting metabolites, even if the metabolites cannot be identified at that 
moment.4 In experiments seeking metabolite and biomarker discovery, it is useful to 
examine a metabolomic question by altering an independent variable within a system. 
For example, global peak profiles can be monitored with respect to time to compare 
metabolite or biomarker profiles over disease progression. The resolved metabolites 
within that sample set can be analyzed relative to control samples or samples from 
various disease time-points. Indeed, a review from Newgard et al.10 describes 
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untargeted metabolomic techniques used to seek biomarkers of metabolic diseases 
including diabetes and cardiovascular disease.  
An unknown peak presence or significant variation in peak area could lead to 
metabolite identification. Metabolite libraries such as METLIN and the Human 
Metabolome Database are available for untargeted comparisons to known metabolites, 
and their collections continue to expand.1,4,24 Metabolite discovery may direct future 
investigations and/or form new hypotheses.1 For this reason, relative comparisons of 
peaks using an untargeted LC/MS approach provide useful insight into potential 
metabolites of interest and/or biomarkers.1,22 Continuous investigation of significant end 
products will lead to a targeted approach. 
Targeted Approach: While untargeted approaches aim to visualize all of the 
small molecules and metabolites in a system, targeted approaches focus on analyzing a 
few, select molecules.1 Usually these molecules are previously identified and are being 
studied in relation to a pathway or disease.1 In many cases, these approaches aim to 
closely observe disease biomarkers, even at low concentrations.22 Because the features 
of the desired molecule are known, the sample preparation stage can be tailored to 
achieve high absolute recovery. Using a targeted approach requires highly sensitive 
instrumentation, including MS analyzers capable of single reaction monitoring (SRM) or 
multiple reaction monitoring (MRM). When these modes are utilized, trace amounts of 
metabolites can be detected in complex samples to the level of nanomolar and 
picomolar concentrations.3,15 For example, this strategy is often utilized to study drug 
metabolism and drug toxicity in vivo.25 These protocols are incredibly useful for 
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visualizing known metabolites in samples, although the most valuable feature of using a 
targeted metabolite strategy is the ability to precisely quantify metabolites.10 
 Exact quantification of biomarkers and metabolites is useful for clinical insight. 
For example, trace metabolite and/or biomarker quantification can be used to support 
diagnosis of a medical condition or generate a toxicity threshold.22 In order to achieve 
this level of precision and accuracy, the metabolite of interest must be compared to a 
standard control molecule.10 The standard molecule is generally a stable isotope 
containing 2H or 13C, a deuterated isotope of the same metabolite, or a chemical 
analog.10 If using an isotope, this strategy can also be called isotope dilution mass 
spectrometry.15 When selecting an internal standard to use for LC/MS analysis, it is best 
to obtain a standard such as an isotope that is nearly identical in chemical properties. 
This will result in the greatest accuracy since it will allow for the same sample 
preparation and LC/MS protocol for both the metabolite of interest and the internal 
standard.15 The peak area of the metabolite of interest can be normalized against this 
internal standard and compared to a calibration curve of known concentrations and 
peak areas.1,10 The precise level of quantification from targeted analysis is usually the 
end-result of a hypothesis that was initially formed through untargeted metabolomic 
data processing.1 Recent developments support combining the untargeted and targeted 
strategies in order to enhance data processing capabilities and timeliness.  
 Combining Approaches: The hypothesis-generating untargeted approach and 
hypothesis-based targeted approach are used to supplement each other in 
metabolomics research.1 However, the protocols for each have previously been kept 
separate due to differences in instrumentation and distinct resolution goals: the 
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untargeted approach aims to achieve a global metabolite profile while the targeted 
approach is optimized for individual metabolite monitoring and quantification.1 Both of 
these approaches are high-throughput individually, but being able to utilize these 
approaches in one protocol would undoubtedly enhance the power of metabolomic 
research potential.  
 Gao et al.22 developed a method appropriate for coupling an untargeted 
metabolomic strategy with a targeted quantification feature on LC/MS/MS 
instrumentation. In that study, they screened cancer-related metabolites having a vast 
range of polarities. They utilized a dual LC method along with two MS approaches: 
parallel reaction monitoring (similar to MRM) for targeted quantification and all ion 
fragmentation for untargeted analysis. This method was able to visualize and quantify 
88 of the 110 chosen metabolites using their coupled method. Ghosson et al.26 also 
utilized a simultaneous targeted and untargeted LC/MS strategy to study the plant 
metabolome. These studies highlight the future of metabolomics research and LC/MS 
capabilities, which will allow for enhanced comprehensiveness and robust data analysis.  
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OBJECTIVES 
 The various strategies for studying metabolomic questions are addressed above. 
These strategies and techniques are capable of answering complex research questions, 
including the ones herein. The investigations described utilize a metabolomics workflow 
including multiple strategies: MS, NMR, flash column chromatography, TLC, and 
LC/MS. Liquid chromatography coupled to mass spectrometry was chosen as the end-
product analysis in this workflow. Compared to other techniques, LC/MS has the highest 
metabolite resolution with the least amount of bias. For that reason, LC/MS was our 
method of choice to answer main research questions in the following investigations.  
However, LC/MS is highly variable. Robust methods must be initially created in order to 
guarantee metabolite coverage, sensitive detection, and accurate quantification. To 
utilize this strategy, all method parameters and validations needed to be generated in-
house at the University of Illinois School of Chemistry CORE laboratories. Both 
untargeted and targeted LC/MS approaches were used. The aims of this work were to:  
 
1. Precisely quantify the amount of imidacloprid in pig urine samples utilizing 
targeted LC/MS/MS with MRM mode 
2. Purify the main bile alcohol, 5α-cyprinol sulfate, isolated from crude bile 
and confirm its identity using column chromatography, TLC, MS, and NMR  
3. Examine the metabolism of pure 5α-cyprinol sulfate in carp intestine as 
well as zebrafish intestinal cultures in order to visualize untargeted 
metabolic profiles and relate this to host bile signaling pathways 
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CHAPTER 2: Development of a method to quantify imidacloprid levels in urine 
from pigs experiencing an immune challenge and imidacloprid supplementation 
ABSTRACT 
Neonicotinoids, including imidacloprid (IMI), are commonly applied to agricultural 
fields as an insecticide. For many years, neonicotinoids have been considered harmless 
to mammalian species, although this claim is currently being disputed. In this work, the 
amount of IMI was quantified in 6 pig urine samples with solid phase extraction (SPE) 
sample cleanup followed by liquid chromatography-tandem mass spectrometry 
(LC/MS/MS). D4-imidacloprid (D4-IMI) was used as an internal standard. The SPE 
cleanup method demonstrated a percent recovery of 92%. Treatment IMI quantification 
in pig urine was achieved by normalizing to known D4-IMI peak areas obtained from an 
IMI standard curve. The LC/MS/MS method utilized a limit of detection (LOD) of 25 fg/µl 
for IMI. The limit of quantification (LOQ) for IMI in the method was determined to be 50 
fg/µl. Pigs in the treatment group showed significant IMI concentrations in urine 
averaging 117.9 pg/ml, while control pigs did not have IMI concentrations above the 
LOD. In the full study, levels of IMI detected in pig urine were related back to negative 
side effects in pigs, including lower body weights and increased incidences of 
hypothermia. Our method critically confirmed this correlation, and the first author in that 
study reported that IMI supplementation for 14 days altered virus-specific responses 
and showed a strong trend of increased viral dissemination of treatment pigs challenged 
with porcine reproductive and respiratory syndrome virus (PPRSV). These results were 
published in Scientific Reports in August 2018 (doi: 10.1038/s41598-018-30093-6). 
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INTRODUCTION 
 
Neonicotinoids, including imidacloprid (IMI), are a family of nicotine-analog 
insecticides that are applied through spray techniques, drip irrigation, and/or injection 
into the plant. 27 Once applied to crops, neonicotinoids function systemically; they are 
absorbed by the plant and distributed to all other tissues.28 Insects that consume the 
neonicotinoids suffer a breakdown of their central nervous system, and this prevents 
herbivorous insects from damaging the plant, which also protecting crops from viruses 
carried by those insects, leading to higher crop yields.29 Neonicotinoids are the most 
widely used insecticide in the world, with IMI being the first introduced to market and the 
most prevalent neonicotinoid is the world.29 In 2010, it was estimated that 20,000 tons of 
IMI were produced for worldwide use.29 Investigation into the effects of IMI is warranted 
due to its commercial relevance and high environmental burden.  
Neonicotinoids are persistent in the environment. The half-life of neonicotinoid 
analogs varies greatly, but a review of studies showed that IMI has a half-life of 28 to 
1230 days in laboratory settings.30 This means that with multiple applications, 
neonicotinoids will accumulate in the environment. Those high levels of neonicotinoids 
can potentially leach into ground water sources. In fact, IMI was detected in 89% of 
surface water samples taken in California with 19% of samples exceeding limits put in 
place by the United States Environmental Protection Agency (EPA).31 The observed 
environmental persistence and high level of water contamination indicate the potential 
for significant effects of neonicotinoids on the surrounding ecosystem.  
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The harmful effects of neonicotinoids are evident when observing the ecology of 
honeybees since the introduction of neonicotinoids in 1991.29 Honeybees are uniquely 
susceptible to pesticide use in their native environment. They do not migrate more than 
a few miles from their local hive to find pollen sources that are essential for their honey 
production.32 So, levels of neonicotinoids found in honey can directly be used to indicate 
levels of pesticides present in that local environment.33 One global study found that 75% 
of 198 honey samples taken from all continents (excluding Antarctica) was 
contaminated with at least one neonicotinoid; 45% of honey samples had more than 
one neonicotinoid present.32 This contamination does have detrimental effects on the 
bees, which are a necessary part of the worldwide ecosystem due to their frequent 
pollination of plant species.34 Multiple studies show that neonicotinoids affect bee 
reproduction, behavior, and mortality.30, 34, 35 This insight has brought global attention to 
the uncontrolled and risky use of neonicotinoids in agriculture.  
The critical threat of neonicotinoid exposure to bee populations is one of the main 
reasons why the European Union banned use of 3 major neonicotinoids, imidacloprid, 
clothianidin and thiamethoxam, from agricultural use in 2013. In 2018, they expanded 
this legislation to ban nearly all neonicotinoid use. The United States allows the use of 
neonicotinoids for insecticide purposes, although the EPA has taken steps to protect 
contracted bee populations important to local pollination from experiencing 
neonicotinoid contamination.36 However, the government recently lifted previous bans 
that protected wildlife refuge areas from neonicotinoid exposure in the United States. 
This suggests that new legislation is unlikely to be passed without more in-depth 
investigations of the harmful side effects of mammalian neonicotinoid exposure.  
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Low neonicotinoid exposure is generally regarded as safe for mammalian 
species. Neonicotinoids are agonists of the nicotinic acetylcholine receptor in the central 
nervous system, giving them their effective insecticidal properties.37 The neonicotinoids’ 
specificity for invertebrate nicotinic acetylcholine receptor was found to be much higher 
than for vertebrates;37 for that reason, low levels of neonicotinoids were not initially 
expected to modulate mammalian health. More recently, though, this statement has 
been put into question. Neonicotinoids have been detected in fruits, vegetables, and 
cereals prepared for human consumption.38 Once ingested, IMI has the potential to be 
absorbed in the intestine.39 Even at low levels, neonicotinoids can modulate mammalian 
health, including suppression of the immune system.40 This is expected to confer 
deleterious effects on humans as well as food animal species which are already 
vulnerable to viral disease. Herein, we describe a method useful for quantifying IMI 
levels in urine to support studies that link neonicotinoid exposure to mammalian 
physiology and immunology.  
MATERIALS AND METHODS 
Reagents and materials: Isotope labeled D4-IMI (Sigma Aldrich, St. Louis, 
MO) was prepared as a stock solution (150 pg/μl) in LC/MS grade acetonitrile (ACN) 
and was used as an internal standard for IMI quantification in treatment urines. IMI 
and acetamiprid (Sigma Aldrich) were used for method validation and were also 
prepared as stock solutions (150 pg/µl) in ACN. Chemical structures of these 
neonicotinoid used can be seen in Figure 2.1. In initial experiments, Oasis MCX 
columns (Waters, Millford, MA) were used for urine solid phase extraction. For final 
solid phase extraction procedure, Bond Elut PCX 30 mg polymeric strong cation 
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exchange columns (Agilent Technologies, Santa Clara, CA) were used. Other 
reagents used for sample preparation and cleanup included LC/MS grade ACN, 
ammonia solution (7 M), phosphoric acid (2% v/v), formic acid (2% v/v), and HPLC 
grade methanol purchased from Fisher Scientific, Pittsburgh, PA. 
IMI treatment and PPRSV infection: Animal treatments were carried out 
under the direction of J. Hernandez and Dr. Andrew Steelman after approval from the 
Institutional Animal Care and Use Committee at the University of Illinois Urbana-
Champaign. Animal work was performed using the guidelines provided from the 
National Institutes of Health. Male and female Yorkshire piglets were obtained day 2 
or 3 after birth. They were assigned into one of four treatment groups including IMI 
supplementation and PPRS challenge. Those piglets included in the IMI groups 
received IMI (5 mg/kg/d; 95% purity, BOC Sciences, Shirley, NY) in milk replacer 
(Milk Specialties; Eden Prairie, MN) once a day for a period of 14 days. Vehicle 
controls received dimethyl sulfoxide in milk replacer. The P129-BV strain of PRRSV 
(1 × 105 TCID50) was administered to piglets between days 5–7 of age. Vehicle 
controls were inoculated with 1 ml sterile PBS solution and housed separately to 
avoid cross-contamination.  
SPE cleanup of pig urine: Urine samples were collected from the bladders of 
vehicle control pigs (n= 3) and IMI treatment pigs (n= 3) on day 14 of the animal trial. 
All urine samples were prepared as followed: 5 μl of urine (IMI treatment group or 
vehicle control) and 5 μl of 150 pg/µl D4-IMI stock solution was mixed with 990 μl 
water. The diluted urine was added to 1 ml of phosphoric acid solution (2%). The 
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mixture was incubated at 37 °C for 10 min with gentle shaking in order to  acidify the 
urine sample and break up any urine crystals. 
For clean LC/MS/MS results, IMI and internal standard were extracted out of 
urine. Initial experiments used Oasis MCX columns. The columns were primed using 
1 ml methanol (100%) followed by 1 ml water. The sample (1 ml) was run through the 
column using a vacuum chamber. It was washed with 1 ml formic acid (2%) followed 
by 1 ml of methanol (100%). Products were eluted using 1 ml ammonium hydroxide 
(5%) in methanol (95%). The methanol was evaporated under a stream of nitrogen 
gas and resuspended in 170µl ACN for injection on to LC/MS/MS. 
The SPE procedure ultimately leading to quantification of IMI used Bond Elut 
PCX columns. The protocol was adapted from Ueyama et al.41 In brief, Bond Elut 
PCX columns were preconditioned using 500 μl of 5% ammonia solution in methanol 
combined with ACN (1:1. v/v) followed by 500 μl water. The 2 ml urine/phosphoric 
acid sample containing spiked internal standard was then loaded on to the SPE 
column. The initial drop of solution was pulled through the column by vacuum, then 
gravity was used to elute the remaining sample. This was followed by 500 μl of formic 
acid solution (2% v/v) and 3 min of dry time using the vacuum. A clean glass catch 
tube was used collect the eluate, which was eluted drop-wise with gravity using 500 μl 
of 100% methanol. The final elution was evaporated under a stream of nitrogen gas 
at room temperature. The dry residues were sonicated for 10 min after addition of 
170 μl of ACN. This sample was centrifuged at 19,500 × g for 5 min and the 
supernatant was used for LC/MS/MS analysis in MRM mode. 
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Acetamiprid  
Imidacloprid 
D4-Imidacloprid 
   
 Figure 2.1: Chemical structures and molecular weights for neonicotinoids of 
interest in this study. 
255.6 g/mol 
259.6 g/mol 
222.7 g/mol 
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LC/MS/MS with MRM mode: LC/MS/MS was performed on a Waters Acquity 
UPLC coupled with a Waters Synapt G2-Si ESI MS (Waters, Millford, MA). Samples 
were separated on a Waters Cortecs UPLC C18 column (1.6 μm particle size) (2.1 mm × 
50 mm) with a column temperature of 25 °C. The injection volume was 10 μl for each 
sample. The mobile phase consisted of Solvent A: H2O containing 5% ACN and 0.1% 
formic acid, and Solvent B: ACN containing 5% H2O and 0.1% formic acid. The initial 
mobile phase was 100% Solvent A. Over the next 2.5 min Solvent B was increased 
linearly until reaching 5% and was increased linearly again to 70% over the next 1.5 min 
period. At 5 min, the mobile phase was 100% Solvent B before returning to the initial 
mobile phase over the next 2 min. The flow rate was 20 μl min−1 with a total run time of 
7 min. The MS/MS utilized ESI in positive ion mode with the addition of MRM in order to 
monitor daughter ions and increase sensitivity. Nebulizer gas pressure (87 psi) was 
maintained at 600 °C and gas flow was 1000 L hour−1. High purity nitrogen was utilized 
as the collision cell gas and the capillary voltage was set at 3,000 V in positive mode. 
Raw chromatographs and mass spectrometry data were processed with Waters 
MassLynx 4.1 Software. The first daughter ions of IMI and D4-IMI were used to establish 
MRM channels. Peak area ratio of urinary IMI to D4-IMI was used for quantification.  
LC/MS/MS parameters and SPE recovery: An internal standard with a different 
retention time than IMI was needed in order to obtain accurate quantification in urine 
samples. Acetamiprid and D4-IMI were both used for internal standards and analyzed 
on LC/MS/MS. A standard curve of IMI in methanol was used for quantification in urine. 
A concentrated sample of IMI was serial diluted to obtain an R2 value and line of 
regression equation. The LOD was defined as the lowest concentration of imidacloprid 
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that was detected with a signal to noise ratio of 3:1. The LOQ for this instrument was 
defined as a signal to noise ratio of 10:1 based on the peak area. The percentage of 
recovery for the SPE was determined by comparing the peak areas of D4-IMI stock 
solutions with and without the SPE procedure performed in triplicate. 
Quantification of IMI in urine: A series of calculations were needed in order to 
normalize IMI peak areas in urine relative to peak areas of 5 µl spiked D4-IMI stock 
solution at a known concentration of 150 pg/µl. Normalized peak areas were used in the 
standard curve equation to compute IMI levels in treatment pig urine. The calculation 
scheme was used as followed:  
 
 
 
 
 
 
 
( 
( 
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RESULTS 
Neonicotinoid detection on LC/MS/MS: To verify the LC/MS/MS method and 
determine retention times for the compounds of interest, we used neonicotinoid 
standard stock solutions. Initially, we thought that acetamiprid (m/z = 223.1; retention 
time = 2.13 min) could be used as an internal standard useful for the quantification of 
IMI (m/z = 256.1; retention time = 2.13 min) for LC/MS/MS quantification since both 
compounds are neonicotinoid analogs with different masses and retention times 
(Figure 2.2). As observed in Figure 2.2, the peak heights for acetamiprid and IMI are 
significantly different, despite that they were spiked into blank urine at the same 100 
µM concentration and run through the same SPE procedure. This suggests that 
quantification of IMI using the neonicotinoid analog acetamiprid would not be 
accurate due to the molecules’ inherit differences.  
We decided it was best to proceed using D4-IMI as an internal standard. Using 
the isotope-labeled form of the IMI compound allows for more accurate SPE recovery 
and LC/MS quantification. Using D4-IMI meant that we needed to adapt a sensitive 
LC/MS/MS protocol using MRM mode to differentiate IMI and D4-IMI peak areas. The 
MRM channels were established using the instrumentation at the University of Illinois 
School of Chemistry CORE mass spectrometry laboratories, and we determined the 
appropriate daughter ions for D4-IMI and IMI. For IMI, the daughter ions were shown 
to be 175.1 m/z and 209.1 m/z. The chemical structures for fragmented ions as 
previously reported42 is shown in Figure 2.3. For D4-IMI, the daughter ions were 
shown to be 179.1 m/z and 213.1 m/z. (Figure 2.4) These ions correspond with 
previous studies,41,42 and it also accurately represents the four deuterated ions 
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present in the internal standard, D4-IMI. From this, we decided to monitor the first 
daughter ion (IMI = 175.1 m/z; D4-IMI = 179.1 m/z) for quantification purposes. This 
ion was consistently prominent in all LC/MS/MS chromatographs used for analysis 
and quantification.   
Selection of SPE cartridge for purification and detection of IMI in pig 
urine: Initially, Oasis MCX SPE columns were used for SPE. We were unable to 
detect the IMI mass ion when testing a blank pig urine sample spiked with IMI above 
the LOD. This suggested that IMI irreversibly binds to the MCX column. We 
proceeded using Bond Elut PCX columns which showed clear elution peaks of both 
IMI and D4-IMI when blank pig urine samples were analyzed.  
SPE recovery and LC/MS/MS parameters: The absolute recovery of Bond 
Elut PCX column was determined by peak area comparisons with and without SPE. 
Average values were obtained by running samples in triplicate. The peak areas in 
LC/MS/MS with MRM mode using 5 µl of 150 pg/µl D4-IMI stock solution diluted in 1 
ml of water averaged 87.1. Urine samples containing the same amount of D4-IMI 
processed by SPE averaged a peak area of 80.2. By comparing these values, the 
absolute recovery of IMI using this SPE method was determined to be 92%. A total of 
five different IMI concentrations and respective peak areas were used to create the 
standard curve. The standard curve ranged from 50 fg/µl to 25,000 fg/µl with an R2 
value of 0.9998 and a linear equation of Y= 16.35(x) +1633 (Figure 2.5). This 
equation was used for subsequent quantification. The LOQ was 50 fg/µl and the LOD 
was 25 fg/µl of IMI in urine samples in this method. 
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Figure 2.2: LC/MS chromatograph showing differential retention times of IMI 
(molecular weight = 255.7 g/mol) and acetamiprid (molecular weight = 222.7 g/mol) 
stock solutions spiked into blank urine at 100 µM. The retention time for IMI remains 
consistent at 2.03 min with a mass ion of 256.1 m/z. The retention time for 
acetamiprid was 2.13 min with a mass ion of 223.1 m/z.  
 
223.1 m/z 
Imidacloprid 
  256.1 m/z 
Acetamiprid 
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Imidacloprid Parent Ion 
Daughter Ion 1 Daughter Ion 2 
256.1 m/z 
175.1 m/z 209.1 m/z 
Figure 2.3: Chemical structure of IMI parent ion at 256.1 m/z with chemical 
structures of daughter ions at 175.1 m/z and 209.1 m/z after being fragmented and 
detected on MS/MS.  
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Figure 2.4: Mass spectra showing both daughter ions of IMI and D4-IMI. Peak areas 
for D4-IMI and IMI were obtained by monitoring the first daughter ions at 179.1 m/z 
and 175.1 m/z, respectively. 
 
 
 
B.  D4 - Imidacloprid 
A. Imidacloprid 
Daughter ion 1 
Daughter ion 2 
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Figure 2.5: The standard curve between 50 fg/µl to 25,000 fg/µl used for 
quantification of IMI using peak areas retained at 3.60 min and corresponding to 
mass ion 175.1 m/z.  
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PIG GROUP D4-IMIDACLOPRID 
PEAK AREA 
IMIDACLOPRID PEAK 
AREA 
LEVEL OF 
IMIDACLOPRID IN 
URINE (pg/ml) 
VEH 107.8 N.D N.D 
VEH 124.7 N.D N.D 
VEH 82.2 N.D N.D 
IMI 60.2 3277.1 128.2 
IMI 104.3 5672.9 124.2 
 IMI 76.1 3087.0 101.4 
 
 
Table 2.1: LC/MS/MS peak areas of D4-IMI spike and IMI in pig urine from vehicle 
controls (VEH) and imidacloprid treatment group (IMI). Quantified values for IMI in pig 
urines are listed in the last column.  
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Figure 2.6: Images in Scientific Reports.43 (A) Representative chromatographs of IMI 
and D4-IMI daughter ions in pig urine samples. Top: Urine from IMI treatment pigs with 
D4-IMI spike shown in blue. Bottom: Urine from vehicle control pigs with D4-IMI spike in 
blue. Minor migrations in retention times due to instrument error. (B) Chart of IMI 
quantification in pig urine (pg/ml) from vehicle and IMI treatment groups. N.D = not 
detected on LC/MS/MS. Results are means ± S.E. ***p < 0.001 by student’s t-test. 
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Quantification of IMI in pig urine: Urine from vehicle controls and IMI treatment 
was quantified using the peak areas from LC/MS/MS MRM mode analysis. Vehicle 
control urine had levels of IMI that were below the LOD. The D4-IMI spike was used to 
confirm the method in the control urines, and peaks areas of 107.8, 124.7, and 82.2 
were detected at mass ion 179.1 m/z. IMI treatment urine had IMI peak areas at 
3277.1, 5672.9, 3087.0 at mass ion 175.1 m/z. The D4-IMI spike was detected at 
mass ion 179.1 m/z with peak areas of 60.2, 104.3, and 76.1 to verify the method. 
This data was normalized to the absolute recovery of D4-IMI and applied to the 
standard curve Y= 31.692x + 31.877. The total levels of IMI in treatment urine 
samples was determined to be 128.2, 124.2, and 101.4 pg/ml. Values are 
summarized in Table 2.1 and represented in Figure 2.6. 
DISCUSSION 
 In this set of experiments, we developed a SPE urine cleanup procedure and a 
highly sensitive LC/MS/MS method utilizing MRM mode to quantify levels of IMI in pig 
urine. Pigs receiving IMI supplementation in their diet had significantly elevated IMI 
levels excreted in their urine. Pigs receiving a vehicle control did not have any IMI 
present above the LOD. This method was critical to the current study which investigated 
how IMI exposure modulates mammalian immune response to a viral challenge. The 
complete study demonstrated that pigs with elevated IMI levels detected in their urine 
had lower body weights and increased hypothermia incidences that were both 
independent of viral infection state.  
 Much of the research exploiting the detriments of IMI exposure is focused on 
concerns over honeybee ecology. However, levels of IMI in mammalian biological fluids 
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have also been examined before due to incidences of acute poisoning upon ingestion 
as well as concerns over low-dose IMI exposure.44–47 In other studies, the levels of IMI 
in urine have also been quantified on LC/MS/MS using MRM mode.41,42,47 The 
LC/MS/MS method we developed to quantify IMI has an LOD of 25 fg/µl. This LOD is 
80-fold, 8-fold, and 4.8-fold more sensitive than similar studies. The LOQ in our study is 
50 fg/µl which is 200-fold, 40-fold, and 7.2-fold more sensitive than those same similar 
studies. The absolute recovery of IMI from SPE for our study was 92% using the Bond 
Elut PCX columns. This recovery is superior to two other urine cleanup methods 
examined.41,47 The third method had a higher IMI absolute recovery, but this method 
utilized diatomaceous earth-assisted extraction columns (ExtreLut NT3) instead of the 
PCX polymeric cation exchange columns used here. 
We did not examine IMI metabolites when considering our quantification 
methods. Proenca et al.47 was the first study to examine IMI in human biological fluids 
and tissue homogenates. They reported that IMI is almost completely degraded to 6-
chloronicotinic acids in the intestine.47 However, they did not recover any metabolites in 
human fluid and tissue samples. Taira et al.48 detected IMI metabolites from urine of 
mice that were dosed with IMI and suggests that IMI metabolites may be recovered in 
human urine. While this was their own suggestion, they were not able to quantify any 
IMI metabolites in the human urine samples available to them at that time. Ueyama et 
al.41 reported that IMI is not metabolized in the human body and because of that, 
monitoring the intact IMI ions may lead to a more precise estimation. Likewise, 
Yamamuro et al.42 did not report any IMI metabolites in human urine samples. Indeed, 
we identified the intact IMI ions in treatment pig urine at 175.1 m/z and 209.1 m/z as 
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previously reported.41,42 While it seems unlikely that IMI is metabolized in humans and 
other mammals, we did not consider the possibility of metabolites during method and 
experimental design. To do this, we would have needed to examine the peaks in the full 
scan LC/MS chromatogram of crude urine samples. 
The results in the full study highlight the need to investigate the effects of IMI on 
immune function and mammalian health. IMI levels affect immune integrity when 
fighting viral infection, but the infection is not a prerequisite for all adverse effects. The 
pigs in this study were subjected to PRRSV, which is estimated to cost the swine 
production industry $664 million annually.49 This clearly demonstrates the significance 
of PRRSV in swine health and the need to reduce production losses. Although, the pigs 
without PRRSV infection also had adverse responses to IMI supplementation. All pigs 
receiving IMI in their diet had lower body weights and increased hypothermia 
incidences, which emphasizes the importance of further investigations into 
neonicotinoid contamination levels in food animal production systems. The 
quantification method developed here may be useful in those future studies of 
agricultural animals and neonicotinoid exposure. 
Additionally, it would be beneficial to establish no-observed-adverse-effect levels 
(NOAEL) for food production animals. Neonicotinoids function systemically in insects, 
but they are often considered safe for mammalian species as long as the exposure 
remains under a certain limit. IMI is one of the most commonly applied neonicotinoids to 
crop fields and other plants.1 The prevalent IMI use means that food production animals 
are at risk for low-dose exposure due to environmental and feed contamination. The 
reference dose (RfD) for IMI in humans is 0.057 mg/kg/day as set by the EPA. This is 
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determined by RfD values for rats (5.7 mg/kg/day) divided 100-fold. In this study, pigs 
received IMI at levels of 4.7 mg/kg/day. 43 The NOAEL of IMI has not yet been 
determined for pigs and other production animals. Assigning a NOAEL value for 
production animals could potentially result in limited IMI use in agriculture, leading to a 
healthier food animal population. This method can be used to determine those values.  
 The method developed here uses SPE and LC/MS/MS with MRM mode as a 
sensitive, previse way to quantify IMI in urine samples. It can be used broadly to support 
the work of various studies that examine IMI and potentially other neonicotinoid levels in 
mammalian health. In the context of this study’s application, it can also be used to 
establish NOAEL values that do not currently exist for food production animals at risk for 
neonicotinoid exposure. This would be a worthwhile area of investigation in an attempt 
to minimize production losses due to viral infection. 
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CHAPTER 3: Bile acid and bile alcohol bacterial metabolism in the zebrafish gut 
microbiome 
ABSTRACT  
 The main bile component in carp (Cyprinidae) and zebrafish (Danio rerio) was 
purified from a crude source and its metabolism was examined in gut contents and 
intestinal cultures. Bile acid structure affects cellular signaling, which means that the 
extent of bile acid/alcohol metabolism is important for future studies of cellular signaling 
in the zebrafish model. The predominant bile alcohol in both carp and zebrafish bile, 5α-
cyprinol sulfate (5αCS), cannot be purchased commercially. Therefore, 5αCS was 
purified from crude bile of the Asian Grass carp (Ctenopharyngodon idella), and the 
chemical structure was verified using nuclear magnetic resonance (NMR) and mass 
spectrometry (MS). Other bile compounds in the carp identified include 5α-cholestane-
3α,7α,12α,26-tetrol sulfate, and taurocholic acid (TCA) which were identified by liquid 
chromatography mass spectrometry (LC/MS). The LC/MS results of crude carp gut 
contents suggested that the endogenous microbial community likely epimerizes α-
hydroxyl groups on 5αCS, which requires hydroxysteroid dehydrogenase (HSDH) 
activity. Analysis of zebrafish gall bladder content suggest that 5αCS makes up 83.4% 
of bile acids/alcohols, with the other components being 8.8% TCA and 7.8% 5α- 
cholestane-3α,7α,12α,26-tetrol sulfate. Zebrafish intestinal homogenates were grown in 
the presence of pure 5αCS, TCA, and allocholic acid (ACA) to investigate the potential 
bile acid metabolizing species in the zebrafish intestine. The bile metabolites of aerobic 
and anaerobic zebrafish bacterial cultures were examined using LC/MS. It was 
determined that 5αCS and ACA were metabolized by HSDHs in the various bacterial 
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communities. TCA was metabolized by bile salt hydrolase (BSH) enzymes in zebrafish 
intestinal communities. This is the first investigation into bile acid metabolism within the 
gut microbiome of the popular zebrafish model.  
 
INTRODUCTION  
The term “bile salts” includes bile alcohols as well as bile acids, which are found 
in every vertebrate species.50 Bile salts are surfactant molecules derived from 
cholesterol during synthesis in the liver.51 While bile salts are diverse among 
vertebrates, common structural features between all bile salt variations include a fully 
saturated C19 steroid core and functional group containing an oxygen on C3 and C7, with 
many bile salts also having an oxygen functional group on the C12 position.50 Other than 
those features, the main difference between bile alcohols and bile salts is in their side 
chains: instead of being conjugated to glycine or taurine as other bile salts are, the bile 
alcohol core is almost always conjugated to sulfate.50, 52 C27 bile alcohols have been 
recovered in evolutionary “primitive” species 53 as they are the predecessor of the C24 
bile acids found in evolutionary “higher” vertebrates.50 Several additional enzymatic 
steps and modifications, including bond reduction and hydroxylation, are needed to form 
C24 bile acids from C27 bile alcohols.51 Humans and other higher vertebrates have 
evolved these pathways to synthesize C24 bile acids.52 Some species of reptiles and 
amphibians exhibit bile acids that have a C27 structure, too.52 The chemical structures of 
various bile structures can be seen in Figure 3.1.  
C27 Bile alcohols are commonly identified in various kinds of fish, including the 
hagfish,53 shark,54 carp,55 and zebrafish.50 In Hofmann, et al.50 a survey of teleost fish 
revealed that the majority of bile consists of C24 bile acids. However, cypriniform fish 
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(carp) and zebrafish do not follow this trend since their main bile component is a C27 bile 
alcohol, 5α-cyprinol sulfate (5αCS). Interestingly, carp bile was one of the first animal 
biles used for therapeutic and medicinal use in ancient China, dating back to 
approximately 500 BCE.56 It was used to heal eye diseases and diseases of the 
pharynx.56 In other Asian countries, carp gall bladders have traditionally been consumed 
for medicinal purposes, although some reported poisoning incidences after ingestion.57 
5αCS gained attention due to its correlation with poisoning, and it was later shown that 
5αCS exhibits toxic effects in the liver and kidney upon ingestion in rats and humans.58 
While these ancient uses of 5αCS are fascinating, the main physiological function for 
5αCS is actually dietary lipid digestion and absorption.59 Goto et al.59 determined that 
5αCS purified from Asian carp has a critical micellar temperature below 4°C. This 
signifies that 5αCS has detergent properties and can form mixed micelles in the cold-
water environments where these fish are characteristically found. This study confirms 
that 5αCS has the same dietary lipid emulsification properties as human C24 bile salts, 
both of which participate in a physiological process necessary for dietary lipid digestion, 
enterohepatic circulation.60 
5αCS moves through the carp and zebrafish system through enterohepatic 
circulation.60 Primary bile salts and bile alcohols, including 5αCS, are conjugated with 
sulfates or amino acids in the liver and concentrated in the gallbladder during the 
production of bile. Bile is composed of water with various organic and inorganic 
compounds, with conjugated bile salts or alcohols making up most of the organic 
solutes.61 After a meal is consumed, the gallbladder receives a cholecystokinin hormone 
signal to release bile into the duodenal lumen in order to emulsify dietary lipids. When 
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bile salts reach the distal ileum, approximately 95% of bile salts are actively transported 
through the hepatic portal vein and back to the liver for later use, with the other 5% 
escaping into the host large intestine.62 Once these biliary compounds enter the large 
intestine, they become substrates for bacterial biotransformations, supported by 
evidence comparing the bile pool in the gallbladder to the fecal profile.63 Gut bacteria 
have evolved various enzymes to metabolize bile acids, with these modifications 
resulting in metabolites called primary and secondary bile acids.64 While the exact 
reasons why bacteria generate these secondary bile acids is unclear, certain secondary 
bile acids do display increased levels of toxicity relative to host-derived primary bile 
acids. The toxicity may prevent other bacteria who are sensitive to secondary bile acids 
from colonizing the surrounding area.64 
Additionally, biliary compounds and metabolites are signaling molecules that bind 
to receptors and agonize or antagonize pathways found in various organs throughout 
the body.65 These bile species have been identified as regulatory molecules that bind to 
the farnesoid X receptor-α (FXR). FXR is a nuclear receptor expressed in the liver and 
the intestine that is the major regulator of bile homeostasis.66 FXR is activated by 
conjugated and unconjugated bile acids, and the upregulation of FXR causes inhibition 
of the rate limiting step in cholesterol to bile acid synthesis (CYP7A1).66 This was 
demonstrated by Sayin et al.67 who showed that germ-free mice have a larger bile acid 
pool, achieved through a pathway beginning with the activation of FXR. The presence of 
a conventional intestinal microbiota regulates expression of the rate limiting step in bile 
acid synthesis by creating bile metabolites that have decreased affinity for activation of 
FXR, and this was observed along with decreased levels of circulating bile. Thus, at 
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least in rodents, gut bacteria modulate the size of the bile acid pool by modifying bile 
acid FXR agonists and affecting cellular signaling in the liver. This phenomenon directly 
links the gut microbiome and its metabolites to host cellular-signaling pathways.68 In 
order to obtain holistic knowledge of these physiological processes, it is beneficial to 
study the role of the endogenous microbiome in various animal hosts, including the 
zebrafish. To date, we do not know if the gut microbiome can control the size of the bile 
alcohol pool in zebrafish, as is observed in mice.  
The zebrafish is a popular model for studying vertebrate cellular signaling and 
development. Homology between human and zebrafish is demonstrated by comparing 
digestive physiology. While zebrafish do not have a stomach, they do have a three-part 
regionalized intestine similar to humans:69 the first segment is used for immune 
function70 and lipid absorption, the second is involved in digestion of other 
macromolecules, and the third is used for water and ion transport.69 Zebrafish develop 
rapidly, and the regionalization of the intestine is evident after only five days post-
fertilization.71 The intestine contains differentiated epithelial cells and epithelial folds 
similar to humans with comparative smooth muscle layers and blood vessels.70 
Zebrafish also contain a bile duct from the gall bladder that empties into the intestine 
upon receiving hormone signals.72 The similar yet rapidly developing digestive system 
has made the zebrafish an established comparative model for studies in human 
intestinal development and gut function,71 metabolic disease,72 and liver disease.73  
There are only a few investigations examining the zebrafish microbiota,74,75 with 
one study presenting six bacterial phyla shared with zebrafish, humans, and mouse, 
although the relative abundances vary greatly.76 A novel study by our collaborator, Prof. 
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John Rawls at Duke University, emphasizes the importance of studying the microbiota 
regarding differential gene expression. He showed that when zebrafish and mice 
received a reciprocal bacterial transplant, both species adapted to the transplanted 
bacterial population rather than defaulting to their own native community and native 
abundances.76 Additionally, the reciprocal transplant caused increased expression of 
various metabolic genes in the ileum, including one in the bile acid synthetic pathway 
(ALDH4A1).76 This confirms that the microbiome in zebrafish causes differential gene 
expression in the ileum69,76 as is the case for higher vertebrates.77 However, the role of 
bile metabolites on gene expression and cellular signaling in the zebrafish has not been 
examined. 
The metabolism of mammalian C24 bile acids is a popular area of study since 
these metabolites can activate cellular signaling pathways, including FXR, in various 
degrees of affinity. The activation/suppression of FXR has downstream effects on 
glucose metabolism and lipid absorption.65,67,78 However, there are few studies 
examining biliary composition and bacterial metabolism in fish, even though the 
zebrafish has become an attractive animal model when studying development and 
physiology. Goto et. al59 did study 5αCS metabolism in carp to some extent. The 
authors claimed that the deconjugated product, 5α-cyprinol, was not detected in carp 
intestinal content, which suggests that carp intestinal bacteria may not recognize the 
sulfated bile alcohol.59 However, they made this conclusion using TLC analysis of carp 
intestinal contents, which is highly outdated compared to modern metabolomic 
investigation using highly sensitive LC/MS techniques.5 Additionally, they did not report 
any other potential bile alcohol metabolites produced by the gut bacteria.  
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Further investigations are required in order to determine if any gut bacterial 
species can metabolize 5αCS. This is significant because bacterial species in zebrafish 
that modify 5αCS would also affect FXR expressed in the liver and the intestine, but this 
has yet to be investigated. Figure 3.2 and Table 3.1 represent some of the expected 
5αCS bacterial metabolites carried out by previously identified enzymatic reactions in 
the gut, including:64 hydroxysteroid dehydrogenases (HSDHs), bile salt hydrolase 
(BSH), sulfatases, and those involved in the complex bile acid 7α-dehydroxylation 
pathway. These enzymes may work exclusively or complement one another in the gut 
bacterial population.64 We aim to identify these enzymatic activities by examining 5αCS 
metabolites and other bile metabolites in both carp and zebrafish models.  
Our collaborators at Duke University are studying the effect of FXR expression in 
zebrafish intestine and liver.79,80 5αCS was shown to theoretically activate zebrafish 
FXR in computational docking studies performed by Reschly et al.81 However, 
metabolites of 5αCS and other bile species in zebrafish were not examined. Herein, we 
aim to investigate the metabolism of the main bile components in zebrafish, namely 
5αCS, to determine what metabolites are important when investigating zebrafish 
intestinal gene regulation and FXR signaling. A future goal is to determine the role that 
the endogenous gut bacterial community has on FXR signaling in zebrafish, which may 
serve as a model for understanding human metabolic diseases. The methods generated 
in these experiments will provide insight into the zebrafish intestinal gene expression 
patterns in response to bacterial bile metabolism, and it will enhance comparative 
studies between zebrafish and human.  
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MATERIALS AND METHODS 
Bacterial communities, chemicals, reagents, and materials: Fresh zebrafish 
intestinal content was obtained from sterile dissections performed at Duke University, 
NC. Lactobacillus salivarius JCM1046 capable of bile salt hydrolase activity82 was 
obtained from Professor Paul O’Toole at University of Cork, Ireland. Pseudomonas 
aeruginosa PAO1 encoding a sulfatase83 was sent from Professor John Rawls at Duke 
University, NC. Clostridium scindens ATCC 35704 capable of bile acid 7α-
dehydroxylation84 was cultured from frozen -80 C stocks at UIUC. These three microbes 
were used as reference controls in bile acid and bile alcohol conversion. Corning 
polypropylene conical tubes (15 ml and 50 ml) were purchased from MilliporeSigma 
(San Jose, CA). Organic solvents and other chemicals were purchased from Fisher 
Scientific (Hampton, NH). JT Baker 20 x 20 thin layer chromatography (TLC) plates 
were purchased from Thomas Scientific (Swedesboro, NJ). Solid phase extraction 
cartridges were purchased from Waters (Milford, MA). Allocholic acid was purchased 
from Cayman Chemicals (Ann Arbor, MI), and deuterated-glycocholic acid was 
purchased from Toronto Research Chemicals (Ontario, Canada). All other bile 
standards were purchased from MilliporeSigma. Other materials were purchased from 
either MilliporeSigma or Fisher Scientific. Because we determined that animal-based 
peptones contained detectable bile acids, vegetable peptone and soy peptone both 
from BD Biosciences (San Jose, CA) were used in culture medium. Other ingredients 
include glucose, sodium chloride, dipotassium phosphate, Tween 80, and cysteine 
obtained from Fisher Scientific.  
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Figure 3.2: Chemical structures of some expected 5αCS bacterial metabolites.  
 
 
 
 
 
49 
 
    
 
Table 3.1:  Expected LC/MS characteristics of 5αCS and various potential bacterial 
metabolites carried out by enzymes known to be present in the vertebrate gut 
microbiome 
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TLC visualization and extraction of bile compounds from TLC: Zebrafish and 
carp bile in methanol were examined using silica gel thin layer chromatography plate 
(20 cm x 20 cm, JT Baker). Two mobile phases were used to separate bile alcohols and 
bile acids. BAW mobile phase consisted of butanol: acetic acid: water (85:10:15) mobile 
phase.85 Solvent 25 mobile phase used was n-propanol: isoamyl acetate: acetic acid: 
water (4:3:2:1).86 The respective mobile phase was allowed to migrate up the plate until 
approximately 2 cm from the top. Plates were dried before being sprayed with 10% 
phosphomolybdic acid (w/v) in ethanol. To visualize spots, the plate was baked in an 
oven at 100°C for 10 min.  
To extract bile compounds from the TLC plate after, a sample standard lane was 
sprayed with 10% phosphomolybdic acid (w/v) in ethanol and baked at 100°C for 10 
min. This sample standard lane was lined up to the remainder of the plate, and the 
respective area of silica was scraped off. The silica was extracted twice with 3 ml 
butanol and 3 ml water. The butanol layer was removed after each extraction, 
combined, and evaporated under heat and nitrogen gas.  
Zebrafish bile collection: Dissected zebrafish gall bladders (n= 20) from Duke 
University, NC were suspended in 1 ml of isopropanol. The suspension was vortexed 
and centrifuged (13,000 rpm for 10 min), and the supernatant was evaporated under a 
stream of nitrogen at room temperature. The residues were resuspended in 1 ml of 
100% methanol. For TLC, 20 µl of the methanol extract was spotted on to a silica TLC 
plate. The BAW mobile phase used to separate the bile components. Additionally, a 
diluted (1:100) sample was submitted for LC/MS analysis. 
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Carp bile collection: Asian Grass Carp gallbladders (n= 3) were collected from 
a local supermarket. Bile was collected from each gallbladder and pooled for extraction 
(45 ml). Crude bile was extracted using 9x isopropanol, and the isopropanol-soluble 
portion was removed. The isopropanol layer was concentrated to approximately 20 ml 
under nitrogen. Diluted (1:100) crude bile samples were used for TLC analysis with the 
BAW mobile phase.  
Flash column chromatography of crude carp bile: Purification of carp bile 
acids and alcohols was performed using flash column chromatography as described in 
Goto, et al.59 The flash column (80 cm x 2 cm; 100 ml) was packed 2/3 full with 40 µM 
silica gel. It was assembled using chloroform: methanol (80:20; v/v) mobile phase. The 
concentrated isopropanol-bile mixture was placed on top of the packed silica for 
purification. The eluates of crude bile were collected in 50 ml fractions using a gradient 
of chloroform: methanol (80:20; 500 ml, 75:25; 500 ml, 70:30; 1000 ml, 65:35; 500 ml). 
The fractions were evaporated under nitrogen and resuspended in 100% methanol. A 
dilute sample of each fraction was spotted (30 µl) and examined on a TLC plate using 
BAW mobile phase. Select fractions were chosen for LC/MS analysis.  
Confirmation of pure 5αCS: Pure flash column chromatography fractions and 
TLC spots matching the Rf value for 5αCS were validated using mass spectrometry in 
negative ion mode. 1 mg of pure bile alcohol in methanol was used on a Waters 
SynaptG2-Si ESI MS. The MS data was analyzed using Waters MassLynx 4.1 software. 
Additionally, a 4 mg sample of the evaporated bile alcohol was resuspended in 750 µl of 
deuterated methanol and analyzed by nuclear magnetic resonance spectroscopy using 
an Agilent 600MHz with a 14.1 Tesla 54 mm bore Agilent Premium Compact Shield 
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Superconducting Magnet. Data was visualized at the University of Illinois using MNova 
before being sent to Dr. Genta Kakiyama. The bile alcohol structure was solved 
courtesy of Dr. Genta Kakiyama, Department of Internal Medicine, Virginia 
Commonwealth University. 
Full Scan LC/MS method: LC/MS for all samples was performed using on a 
Waters Aquity UPLC coupled with a Waters Synapt G2-Si ESI MS. Chromatography 
was performed using a Waters Cortecs UPLC C18 column (1.6 µm particle size) (2.5 mm 
x 50 mm) with a column temperature of 40°C. Samples were injected at 1 µl. Solvent A 
consisted of 95% water, 5% acetonitrile, and 0.1% formic acid. Solvent B consisted of 
95% acetonitrile, 5% water, and 0.1% formic acid. The initial mobile phase was 90% 
Solvent A, 10% Solvent B and increased linearly until the gradient reached 50% Solvent 
A and 50% Solvent B at 7.5 min. Solvent B was increased linearly again until it was 
briefly 100% at 8.0 min until returning to the initial mobile phase (90% Solvent A, 10% 
Solvent B) over the next 2 min. The total run was 10 min with a flow rate of 10 µL/min. 
MS was performed in negative ion mode. Nebulizer gas pressure was maintained at 
400°C and gas flow was 800 L/hour. The capillary voltage was set at 2,000 V in 
negative mode. MassLynx was used to analyze chromatographs and mass 
spectrometry data. The limit of detection (LOD) was defined as a 3:1 signal to noise 
ratio using the LC peak data. The limit of quantification was defined as the 10:1 signal to 
noise ratio using the LC peak data.  
A mixture containing 10 µM of the following bile standards were injected onto 
LC/MS for analysis: D4-Glycocholic acid (Internal Standard), TCA, 5αCS, ACA, 
chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), ursodeoxycholic acid (UDCA). 
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The LC/MS method was validated once a single peak for each compound was identified 
with the respective m/z value in negative mode.  
Extraction of carp intestinal content: Whole intestines were removed from 
Asian Carp and collected in 50 ml polypropylene conical tubes. The contents were 
placed in a -80°C freezer overnight and lyophilized to remove all liquid. For LC/MS 
analysis, dry intestinal contents (0.14 g) were resuspended in 1 ml of 90% ethanol and 
sonicated for 30 min to completely dissolve soluble compounds. Furthermore, the 
intestinal content was centrifuged (10,000 rpm for 15 min) and the supernatant was 
filtered (0.45 µm) to remove additional precipitates. Diluted samples (1:100) of the 
filtered supernatant were spotted (30 µl) on to a TLC using BAW mobile phase and also 
injected on to LC/MS in untargeted full scan mode to analyze metabolites. 
Zebrafish bacterial culture preparation- Modified tryptic soy broth (TSB) at 
pH= 7.0 was prepared aerobically and anaerobically for experimental use with the 
composition as follows: vegetable peptone (17.0 g/L), soy peptone (3.0 g/L), glucose 
(2.5 g/L), sodium chloride (0.5 g/L), dipotassium phosphate (2.5 g/L), and cysteine (1.0 
g/L). The intestinal dissections were performed from zebrafish within the same tank 
environment at Duke and were pooled in four biological replicates with six individual 
intestines per replicate. Each replicate was homogenized in 500 µl PBS with 1 mM DTT. 
For each group, the intestinal homogenate was injected using a 23 G needle into an 
anaerobic vial containing modified TSB (1:10 dilution). The rest of the homogenate was 
used to inoculate a 10 ml aerobic TSB culture. Both aerobic and anaerobic cultures 
were incubated at 30°C for 24 hrs before shipment on ice to the University of Illinois. 
Aerobic cultures were incubated with 200 rpm shaking while anaerobic cultures were 
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incubated statically. Upon arrival, substrates (Methanol vehicle, 5αCS, TCA, and ACA) 
were added to fresh medium for a final concentration of 50 µM. The anaerobic and 
aerobic medium were inoculated with the appropriate intestinal homogenates (1:10 
dilution) and allowed to grow at 30°C for an additional 48 hrs. Bacterial reference control 
tubes were also inoculated (1:10 dilution) in modified TSB medium with the selected 
strains of Lactobacillus salivarius, Pseudomonas aeruginosa, and Clostridium scindens 
containing 50 µM bile acid/bile alcohol substrates and cultured at 37ºC for 48 hrs. For L. 
salivarius, 1% Tween 80 growth enrichment was supplemented to media.  
Solid phase extraction of bacterial culture: 1 ml of culture medium containing 
50 µM substrate was used for further SPE. Once grown, the culture was centrifuged 
(10,000 rpm for 5mins) to remove bacterial cells and conditioned medium was removed. 
A 10 µM spike of D4-GCA internal standard was added to each sample before SPE. 
Waters tC18 vacuum cartridges (3ml reservoir, 500 mg sorbent) were used for SPE. 
The method was adapted from Abdel-Khalik, et al as follows.87 Cartridges were 
preconditioned with 100% hexanes (6 ml), 100% acetone (3 ml), 100% methanol (6 ml), 
and water adjusted to pH = 3.0 (6 ml). Conditioned medium was adjusted to pH = 3.0, 
applied to the cartridge, and pulled through dropwise using a vacuum chamber. The 
cartridge was washed with water adjusted to pH = 3.0 (6 ml) and allowed to air dry for 
30 min before being washed with 3 ml of 40% methanol. The 40% methanol fraction 
was tested on TLC to ensure no substrates were being washed off of the column yet. 
Products were eluted using 3 ml of 100% methanol. Final eluates were evaporated 
under a stream of nitrogen and resuspended in 200 µl of 100% methanol for analysis on 
TLC (using solvent 25) or LC/MS. 
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Figure 3.3: Schematic representation of experimental design  
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RESULTS  
TLC, MS, NMR validation of bile species: One major spot with a Rf value of 0.5 
(BAW mobile phase) was identified on TLC after separation of zebrafish gall bladder 
content (n= 20). The major spot from zebrafish gallbladder was scraped from the TLC 
plate and extracted with butanol: water and evaporated under nitrogen. A total of 2 mg 
of purified compound was obtained, which was an insufficient amount for our intended 
experiments. Since zebrafish and carp contain the same bile alcohol profile,50,52 we also 
obtained crude carp bile. The isopropanol-soluble portion of the Asian grass carp bile 
pool also showed a major metabolite at Rf 0.5 (Figure 3.4 A). Thus, these were 
suspected to be the same bile species.  
To obtain enough material for our intended experiments, we utilized carp bile. In 
total, we recovered about 45 ml of crude carp bile from three separate fish. This pooled 
bile sample was run on a TLC plates using BAW mobile phase. A total of 1 mg 
extracted compound was used for mass spectrometry in ESI negative mode. The 
resulting mass ion was 531.3 m/z which is consistent with the expected mass ion of 
5αCS (Figure 3.4 B).  
Another 4 mg of the main compound of carp bile was collected for NMR analysis. 
The chemical shifts were obtained from 1H spectra (Figure 3.5), 13C spectra (Figure 
3.6), COSY spectra (Figure 3.7), and HSQC spectra (Figure 3.8).  The 1H and 13C shifts 
match those previously published for 5αCS (Figure 3.9).88 The COSY chemical shifts of 
our purified bile compound were unique to the 5α configuration rather than the 5β 
configuration. Additionally, the sulfate was determined to be attached to C27 as is true 
with 5αCS (Figure 3.10).  
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Validation of LC/MS method: Bile acid and bile alcohol standard retention times 
were determined in full scan mode on the LC/MS. A reversed-phase C18 column was 
utilized, resulting in hydrophilic bile salts and alcohols having shorter retention times 
than hydrophobic bile acids. We determined whether the following bile species eluted as 
separate peaks before proceeding with further experimentation: D4-GCA, TCA, 5αCS, 
ACA, CDCA, DCA, UDCA. The resulting peaks can be seen in Figure 3.11 with their 
LC/MS features listed in Table 3.2. While the retention time of each compound may vary 
between LC/MS runs due to instrument error and column condition, the retention order 
remained the same. The LOD and LOQ for the substrates TCA, 5αCS, ACA was 
determined. TCA (LOD= 10 µM, LOQ= 30 µM) had higher values than 5αCS (LOD = 
0.25 µM, 0.75 µM) and ACA (LOD= 0.125 µM, LOQ = 0.375 µM) using the mass 
detector. 
Composition of carp bile: 15 flash column chromatography fractions and 
lyophilized intestinal content were separated on TLC using the BAW mobile phase. 
Apart from the 5αCS fraction, several trace bile species were also recovered from the 
flash column. In order to confirm the identity of these minor bile species, flash column 
fractions #3, #9, and #11 were run on LC/MS. A sample of crude bile before the flash 
column was also examined on LC/MS, but the signal: noise ratio was too high for trace 
peaks to be detected well in full scan mode (data not shown).  
As expected, the main bile species was consistent with 5αCS (531.3 m/z) when 
run on LC/MS. Interestingly, the mass ion for 5αCS at 531.3 m/z was detected in a 
much smaller peak at an earlier retention time in both fraction #3 and fraction #9 (Figure 
3.12 B and C). This may be consistent with an epimerized form of 5αCS, which would 
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have a different hydrophobicity and thus a different retention time than the main peak of 
5αCS. The mass ion at 515.3 m/z in carp bile was previously reported and suspected to 
be 5α-cholestane-3α,7α,12α,26-tetrol sulfate by Goto et al.59 When examining the 
LC/MS data, this mass ion was also present at a different retention pattern, with one 
515.3 m/z peak being before the main 5αCS peak and the 515.3 m/z other peak being 
after 5αCS (Figure 3.12 A and C). Again, this is consistent with an epimerized 
compound, which suggests there is HSDH activity in the carp gut. The species detected 
at mass ion 514.3 m/z is likely TCA (Figure 3.12 D) since this was recovered in some 
other carp bile samples. Lastly, the species detected at 529.3 m/z is consistent with a 
dehydrogenated form of 5αCS (Figure 3.12 D). Although, this mass may be consistent 
with a hydrogen loss from the hydroxyl groups at C3, C7, or C12 on 5αCS. We do not 
have enough information at this time to confirm this finding.  
Composition of zebrafish bile: The extracted bile pool from the zebrafish 
gallbladders was run on LC/MS in full scan mode (Figure 3.13 A). Similar to carp, the 
main bile species is consistent with 5αCS (531.3 m/z) making up 83.4% of bile. Minor 
bile species present in carp bile fraction #12 were also present in zebrafish bile, 
including 8.8% mass ion 514.3 m/z, which is assumed to be TCA and 7.8% at mass ion 
515.3 m/z consistent with 5α-cholestane-3α,7α,12α,26-tetrol sulfate (Figure 3.13 A and 
B). A very small peak was also present at mass ion 529.3 m/z which may be a 
dehydrogenated form of 5αCS. Only one peak at 515.3 m/z was observed, suggesting 
that this compound is not epimerized as it potentially is in the carp.  
Determination of metabolites in carp gut contents: Extracted crude carp gut 
contents were examined on LC/MS in full scan mode in order to find predicted 
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metabolites. The resulting chromatograph can be seen in Figure 3.14. The mass of the 
main compounds present is consistent with 5αCS (531.3 m/z) at 7.5 min and 5α-
cholestane-3α,7α,12α,26-tetrol sulfate (515.3 m/z). A peak at 531.3 m/z and 6.4 min 
can also be seen in this chromatograph, which suggests an epimerized form of 5αCS. 
This would be the result of concerted HSDH activity acting on a bile alcohol hydroxyl 
functional group in the intestinal community. Neither TCA nor any of its expected 
bacterial biotransformation products (CA at 407.3 m/z or DCA 391.3 m/z) could be 
detected, but this may be due to instrument sensitivity and the high LOQ of TCA. No 
additional metabolite peaks were observed. This strongly suggests that there is no 
microbial desulfation or bile alcohol 7α-dehydroxylation activity of in the carp intestine.  
Solid phase extraction of bacterial culture medium incubated with bile 
acids/bile alcohol: We were unable to find methods in the literature that attempted to 
extract 5αCS from culture medium. Earlier SPE attempts showed that substrates 
extracted from culture medium had a retention time that differed by several min 
compared to stock substrates in methanol. This was unfit for LC/MS analysis and data 
reproducibility. Therefore, we modified a previous method used to extract cholesterol 
and other steroid hormones out of culture media for LC/MS analysis.87 
 
 
 
 
60 
 
                                                                                                                                       
 
 
 
 
 
 
A. 
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Figure 3.4: (A) TLC image of fish bile samples using BAW mobile phase. ZF = zebrafish 
gall bladder isopropanol extraction. Carp = isopropanol-soluble portion of crude carp 
bile. (B) mass spectrometry of purified main bile component in carp, which matches the 
identity of 5αCS (molecular weight = 532.73 g/mol)  
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Figure 3.9: Solved NMR structure of 5αCS including 13C, 1H, and H/H COSY data. 
Figure courtesy of Dr. Genta Kakiyama. 
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Figure 3.10: (A) Structural differences between the 5αCS and 5βCS stereochemistry 
as demonstrated by NMR chemical shifts. Significantly different peak shifts are 
highlighted in red with the carp bile compound matching 5α configuration (B) 
Chemical shifts representative of a sulfate group on C26 of the compound. Figures 
courtesy of Dr. Genta.Kakiyama 
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Figure 3.11: Standard bile solutions used to validate LC/MS method. Corresponding 
molecular weights are visible on the right side of each chromatograph.  
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Bile Standard Molecular 
Weight 
m/z Approximate 
Retention Time (min) 
Retention 
Order 
D4-Glycocholic Acid 469.63 468.3 5.7  1 
Taurocholic Acid 515.71 514.3 6.3 2 
Allocholic Acid and 
Cholic Acid 
408.57 407.3 6.7 3 
Ursodeoxycholic Acid 392.58 391.3 6.8 4 
5α-Cyprinol Sulfate 532.73 531.3 7.6 5 
Deoxycholic Acid 392.58 391.3 8.1 6 
Chenodeoxycholic 
Acid 
392.58 391.3 8.3 7 
 
 
 
 
 
 
 
 
 
Table 3.2: Table of bile standard solutions with respective molecular weight and mass 
ion (m/z) in negative mode. The retention time at the time of this LC/MS analysis and the 
relative retention order of each compound is also provided. Each respective retention 
order is based on compound polarity.  
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To test that this would work for all of our substrates, 5αCS, TCA, and ACA were 
extracted from modified TSB medium. These samples would serve as method validation 
and substrate/media controls. The extraction procedure was validated on both TLC 
(data not shown) and LC/MS (Figure 3.15). All substrates had differential retention 
times, but the respective time after SPE was unchanged from stock solution controls. 
The internal standard D4-GCA was eluted at 5.62 min, 5αCS was eluted at 
approximately 7.6 min, TCA was eluted at approximately 6.2 min, and ACA was eluted 
at approximately 6.5 min. The unchanged retention times compared to control stock 
solutions and the intact mass ions of all substrates confirmed that this method was 
appropriate for extraction of 5αCS, TCA, and ACA out of zebrafish bacterial cultures.  
Positive controls for bile acid metabolism in culture: Since we did not know 
what 5αCS metabolites to expect in the zebrafish cultures and no metabolites have 
been reported before, we could not chose our positive controls according to 5αCS 
metabolism. Instead, we chose species that were known to modify substrates TCA and 
ACA. Lactobacillus salivarius JCM1046 is known to encode a bile salt hydrolase 
enzyme, which cleaves off the conjugated taurine in TCA, thus generating a primary bile 
acid, CA.82 Clostridium scindens ATCC 35704 is known to contain the bile acid 7α-
dehydroxylation pathway, which transforms liberated CA and/or ACA into secondary bile 
acids DCA or alloDCA, respectively.84 Indeed, these products were recovered as shown 
in Figure 3.16. This experiment confirmed that our method is appropriate for detecting 
bile metabolites in culture using our SPE and LC/MS methods. We also attempted to 
deconjugate 5αCS using Pseudomonas aeruginosa PAO1 with a known sulfatase,83 but 
we were not able to detect the deconjugated form of 5αCS. 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
a
Int. 
 
1        2        3        4        5         6        7       8        9       10      11     
 
TCA 
 
531.3 m/z 
531.3 m/z 
515.3 m/z 
5αCS 
5α-cholestane-
3α,7α,12α,26-tetrol 
sulfate 
531.3 m/z 
514.3 m/z 
515.3 m/z 
529.3 m/z 
Figure 3.12: (A) TLC image of flash column chromatography fractions with suspected 
compound identities #1-11. Int = carp intestinal content after solid phase extraction. (B) 
Respective LC/MS chromatographs of selected column fractions.  
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Figure 3.13: LC/MS chromatograph of (A) crude zebrafish gallbladder pool extraction 
with corresponding m/z and suspected compound identity compared to (B) carp bile 
sample from fraction #11 of flash column chromatography 
 
 
 
 
 
 
 
 
 
A. Zebrafish 
B. Carp 
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Zebrafish bacterial cultures: The bacterial profiles of the zebrafish microbiome 
is known to vary, even with similar genetics and environmental factors.75 To capture a 
high amount of microbial diversity, 24 different intestinal communities were utilized. Our 
collaborators at Duke University randomly divided the intestinal dissections into 4 
groups with 6 intestines per group. This gave us 4 distinct biological replicate 
communities to examine bile metabolic capacity in the zebrafish microbiome. We 
cultured the bacteria under both aerobic and anaerobic conditions in order to achieve 
broad bacterial viability. Since we used full intestinal homogenates in order to grow the 
cultures, we detected levels of 5αCS at 531.3 m/z in all aerobic and anaerobic bacterial 
samples where no additional 5αCS was added (Figure 3.17 A and B). These 5αCS 
peaks were considered the background levels of 5αCS in the zebrafish intestinal 
contents. Another minor peak with a mass ion of 531.3 m/z was also seen at 
approximately 6.4 min in the bacterial control samples, especially for those grown 
anaerobically (Figure 3.17 B). We decided to monitor the size of this peak in cultures 
where additional 5αCS was supplemented to culture in order to determine if this was a 
bacterial product of 5αCS metabolism. The internal standard D4-GCA was not present in 
all samples, but the reason behind this is unknown. 
ACA metabolism in aerobic and anaerobic zebrafish cultures: Aerobically 
and anaerobically cultured zebrafish intestinal communities were incubated with 50 µM 
ACA to examine possible metabolites. The peak corresponding to ACA substrate was 
eluted at approximately 6.5 min (Figure 3.18), which matches the retention time in the 
medium/substrate control sample. All aerobically grown cultures showed evidence of  
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3α,7α,12α,26-
tetrol sulfate 
 
Dehydrogenated 5αCS  
Figure 3.14: Chromatograph of crude carp gut contents showing main composition of 
bile species in the intestine. 
 
 
 
 
 
Epimerized 5αCS  
5αCS  
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Figure 3.15: Chromatographs of internal standard, D4-GCA, with bacterial substrates 
5αCS, TCA, and ACA after SPE of culture media. The clear peaks validate that this SPE 
method can be utilized for bacterial bile metabolism investigation.   
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Figure 3.16: LC/MS chromatographs of positive control samples. In this method, we 
were able to demonstrate bile salt hydrolase activity and 7α-dehydroxylation with various 
bile species. Even though our Pseudomonas strain contains an arylsulfatase, it did not 
recognize 5αCS. No other bile alcohol metabolites were detected.  
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A. Aerobic Cultures 
B. Anaerobic Cultures 
Figure 3.17: LC/MS chromatographs of (A) aerobic bacterial culture 
samples and (B) anaerobic bacterial culture samples without addition of 
substrates. 5αCS peaks and possible epimer at 531.3 m/z were already 
present in intestinal homogenates and are considered background values 
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ACA dehydrogenation. The dehydrogenated ACA was characterized by a mass ion of 
405.3 m/z corresponding to a loss of two hydrogens and an elution time of 5.8 min 
(Figure 3.18 A), suggesting a more hydrophilic metabolite. The dehydrogenated ACA 
metabolite is most likely the result of aerobic HSDH enzyme activity in the zebrafish 
microbiome acting on the α-hydroxyl groups on ACA. We did not detect any secondary 
bile acids in aerobic cultures.  
 The internal standard D4-GCA added to conditioned medium before solid phase 
extraction did not appear in anaerobic communities #1 and #3 (Figure 3.18 B). 
However, this allowed for the detection of an epimerized form of ACA with a mass ion of 
407.3 m/z and eluted at 5.57 and 5.31 min. Anaerobic communities #2 and #4 also 
contain these metabolites, but the mass ion had to be individually selected for in order 
to differentiate from the D4-GCA peak (data not shown). The epimerized ACA 
metabolite is possibly the result of HSDH enzyme activity under anaerobic conditions. 
We did not detect any secondary bile acids/alcohols in anaerobic cultures.  
TCA metabolism in aerobic and anaerobic zebrafish cultures: Aerobically 
and anaerobically cultured zebrafish intestinal communities were incubated with 50 µM 
TCA to examine possible metabolites. The main peak for TCA substrate was eluted at 
approximately 6.2 min (Figure 3.19), which matches the retention time in the 
medium/substrate control sample. Aerobic communities #1, #3, and #4 displayed BSH 
activity which is characterized by the deconjugation of taurine from TCA, resulting in a 
mass ion consistent with CA at 407.3 m/z eluted at approximately 6.5 min (Figure 3.19 
A). It is interesting to note that community #4 had almost complete conversion to CA 
while community #2 displayed no conversion to CA, which suggests that the BSH-
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containing microbes are variable in the zebrafish community. Again, we detected no 
secondary bile acids formed after conversion to CA in aerobic cultures.  
Likewise, the anaerobically cultured communities displayed BSH activity when 
supplemented with TCA, and CA was seen at mass ion 407.3 m/z with a retention time 
of 6.5 min (Figure 3.19 B). In these cultures, community #2 did display activity while 
community #4 did not. This is the opposite effect that was seen in aerobically grown 
cultures. This suggests that at least two different microbes, one aerobic and one 
anaerobic, are capable of BSH activity in the zebrafish microbiome. There was no 
evidence of secondary bile metabolite presence after formation of CA in anaerobic 
cultures.  
5αCS metabolism in aerobic and anaerobic zebrafish cultures: Aerobically 
and anaerobically cultured zebrafish intestinal communities were incubated with 50 µM 
5αCS to examine possible metabolites. The main peak for 5αCS substrate was eluted 
at 7.6 min (Figure 3.20), which matches the retention time in the medium/substrate 
control sample. Aerobic cultures supplemented with 5αCS showed some low level of 
metabolism. A mass ion of 529.3 m/z was eluted right before the substrate 5αCS at 7.4 
min (Figure 3.20 A). The loss of two mass units is consistent with the aerobic HSDH 
activity seen in other bacterial samples. This is likely to be a modified keto-5αCS, 
especially since there is evidence of another 5αCS peak with a mass ion of 531.3 m/z 
eluted at 6.4 min. This new peak at 531.3 m/z was present in all aerobic communities 
tested and matches the expected features of an epimerized 5αCS. No other 5αCS 
metabolites were detected in aerobic cultures.  
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 The anaerobically grown 5αCS cultures further supports evidence for 
epimerization of 5αCS. The 531.3 m/z peak are eluted at 6.4 min increased in all 
anaerobic communities (Figure 3.20 B), suggesting increased epimerization activity 
relative to bacterial controls. Again, this matches our expectations that the reductive 
HSDH activity is higher in anaerobic conditions. In community #4, the native 5αCS and 
epimerized 5αCS are present in near equal levels. The keto-5αCS variant was also 
identified at 5.29 m/z, 7.4 min as it was in aerobic cultures. No other 5αCS metabolites 
were detected in anaerobic cultures. 
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Figure 3.18: LC/MS chromatographs of (A) aerobic bacterial culture samples 
and (B) anaerobic bacterial culture samples with addition of ACA substrate 
A.  Aerobic Cultures 
B.  Anaerobic Cultures 
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A.  Aerobic Cultures 
B.  Anaerobic Cultures 
Figure 3.19: LC/MS chromatographs of (A) aerobic bacterial culture samples 
and (B) anaerobic bacterial culture samples with addition of TCA substrate 
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A.  Aerobic Cultures 
Figure 3.20: LC/MS chromatographs of (A) aerobic bacterial culture samples 
and (B) anaerobic bacterial culture samples with addition of 5αCS substrate 
B.  Anaerobic Cultures 
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Substrate Condition Community HSDHs Epimer BSH 7α-DH 
ACA Aerobic 1 Yes No -- No 
2 Yes No -- No 
3 Yes No -- No 
4 Yes No -- No 
Anaerobic 1 Yes Yes -- No 
2 Yes Yes -- No 
3 Yes Yes -- No 
4 Yes Yes -- No 
TCA Aerobic 1 No No Yes No 
2 No No No No 
3 Yes No Yes No 
4 Yes No Yes No 
Anaerobic 1 No No Yes No 
2 No No Yes No 
3 Yes No Yes No 
4 No No No No 
5αCS Aerobic 1 Yes Yes No No 
2 Yes Yes No No 
3 Yes Yes No No 
4 Yes Yes No No 
Anaerobic 1 Yes Yes No No 
2 Yes Yes No No 
3 Yes Yes No No 
4 Yes Yes No No 
 
Table 3.3: Summary of bile metabolism observed in the zebrafish microbiome. HSDH = 
hydroxysteroid dehydrogenase, BSH = bile salt hydrolase, 7α-DH = 7α-dehydroxylation 
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DISCUSSION 
 Zebrafish are popular models for studying vertebrate intestinal function due to 
their small size, rapid development, optical transparency, and homology to humans. 
Additionally, vast genetic and genomic resources are available, which make zebrafish 
transgenic studies and genetic manipulation a feasible endeavor.89 The FXR gene 
expression and signaling pathways are similar in zebrafish and human, with both 
species expressing this nuclear receptor in liver and intestine.81 In humans, FXR 
regulates bile homeostasis through binding primary C24 bile acids as well as bile 
metabolites produced by bacteria in the gut.64,66 This relationship directly links the gut 
microbiota to host physiology through the regulation of FXR, and this has been a recent, 
intense area of research due to downstream effects on lipid and glucose 
metabolism.67,78 In this set of experiments, we aimed to develop methods useful to 
investigate bacterial bile metabolism in the zebrafish gut. We were unable to purchase 
the main C27 bile alcohol sulfate, 5α-cyprinol sulfate, present in the zebrafish. Instead, 
we obtained whole fishes and purified the major bile alcohol from gallbladder contents. 
Once we verified molecular properties by a combination of TLC and MS and identity by 
LC/MS and 2D-NMR, we determined whether 5α-cyprinol sulfate was metabolized in 
bacterial cultures. For the first time, we report the potential epimerization of a bile 
alcohol hydroxyl group by the zebrafish gut bacteria. This requires bacterial HSDH 
activity, which was also seen in cultures containing TCA and ACA. We were able to 
detect BSH activity active with TCA in the zebrafish microbiota, although we were 
unable to detect bile acid/bile alcohol 7α-dehydroxylation activity in any of bacterial 
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communities. This has implications for FXR signaling because these bile acid/alcohol 
metabolites act as receptor agonists or antagonists in other animal models. 67 
We initially identified dehydrogenation activity in our cultures supplemented with 
ACA. Dehydrogenated bile acids are the end-product of HSDHs within gut bacteria and 
have oxidized ketone groups on either their hydroxyl groups found on C3 and C7 and 
sometimes C12. Epimers are formed due to concerted HSDH activities in the gut 
bacteria, mainly by anaerobic bacterial species. The HSDHs share a similar hydroxyl 
region of activity, but vary in their stereo-specificity.64  Similar to dehydrogenated bile 
acids, epimerization reactions begin by oxidizing the α-hydroxyl group to generate a 
stable oxo-bile acid/alcohol intermediate 68 Then, another HSDH enzyme reduces the 
oxo-bile acid and generates the epimer by flipping the hydroxyl group to the β 
configuration on C3 and C7 and sometimes C12. Many bacterial species encode this 
activity, including Clostridium, E.coli, Bacteroides, and Ruminococcus species,68 
although they are predominantly found in anaerobic bacteria. This was the case in our 
experiment, as the metabolites resulting from HSDH activity were higher in anaerobic 
cultures. Bacterial dehydrogenation of bile acids may be for energy production needs, 
but it can also decrease amounts of hydrophobic bile acids in the gut. Altering the 
physiochemical properties of bile acids to make them less hydrophobic leads to 
decreased toxicity of the surrounding microbes,64 which may explain why the bacterial 
species with the zebrafish microbiome would evolve these enzymes.   
 We also detected BSH activity in our samples testing TCA metabolism. Bile salt 
hydrolase is an enzyme found in gut bacteria that remove the amino acid taurine or 
glycine off of conjugated primary bile acids that enter the intestine. Indeed, we detected 
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a mass that corresponds to unconjugated CA. Since fish generate allo-bile alcohols 
which are epimerized forms of CA, this peak could also be ACA. Unfortunately, we were 
not able to resolve different peak retention times between CA and ACA in this LC/MS 
method. Nevertheless, the detection of bile salt hydrolase activity in the zebrafish is 
intriguing. TCA is present in the bile pool of zebrafish, although the levels are much 
lower than 5αCS, 8.8% and 83.4% respectively. With that in mind, the significance of 
BSH activity on zebrafish physiology in currently unclear.  
The epimerization of 5αCS may be of physiological relevance to zebrafish. The 
epimerized form of 5αCS was not seen in the zebrafish crude bile sample nor the 5αCS 
medium control sample. This product was only seen after the addition of bacteria, which 
confirms that this is a bacterial metabolite. We did not confirm which hydroxyl group on 
5αCS is being modified. To do so, we would need to isolate this compound, confirm its 
purity, and examine it using NMR. Furthermore, it would be interesting to test this 
possible metabolite with the ligand binding domain of FXR to see if it may act as an 
agonist in FXR cellular signaling pathways. This can be done using computational 
structural analysis, or the binding energy can be calculated through isothermal titration 
calorimetry.  
 While the epimerization of 5αCS is a significant find, we did not detect desulfated 
or 7α-dehydroxylated forms. Possibly, there are host selection pressures present that 
the evolution of these enzyme pathways in zebrafish gut microbiota. Similar to C24 
human bile acids, 5αCS forms mixed micelles in the intestinal lumen that aid in dietary 
lipid emulsification.59 While this is a necessary function, the host may favor the intact 
C27 bile alcohol for other reasons, which would select against bacterial species that 
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metabolize 5αCS. Hofmann et al.50 states that the deconjugated bile alcohol is highly 
insoluble, and it would not be able to diffuse through the intestine during bile recycling. 
In the male sea lamprey, C24 bile alcohol sulfates are pheromones to attract mature 
female lamprey.90 Selection against bacteria that modify 5αCS would potentially be 
beneficial to the host if 5αCS is linked with reproductive success as it is in the lamprey, 
and beneficial to microbiota that could move from host to host during mating. 
Pheromone properties of 5αCS would need to be investigated further in order to support 
or disprove this hypothesis.  
 The lack of bile alcohol/bile acid 7α-dehydroxylation activity in the zebrafish 
intestinal community is a surprise. We detected no secondary bile metabolites when 
testing the C27 bile alcohol 5αCS nor the C24 bile species ACA and TCA. We did, 
however, confirm the appearance of secondary bile acid (but not bile alcohol) 
metabolites when using the positive control, human gut bacterium Clostridium scindens. 
Bacteria modify bile acids through the expression of the bile acid-inducible (bai) operon 
encoding the 7α-dehydroxylation pathway, which encode complex enzymes that 
catalyze formation of secondary bile acids DCA and LCA.64,91 Secondary bile acids such 
as DCA and LCA are toxic to both the host and some bacterial species, and that may be 
one reason to explain why the zebrafish does not generate these metabolites. These 
metabolites accumulate in the bile acid pool and are correlated to various host disease 
states, including colon cancer.92  Bacteria that create secondary bile acids may use the 
7α-dehydroxylation pathway as a way to establish a niche and increase their own 
intestinal colonization.64 In this experiment, it appears that zebrafish do not possess any 
bacterial species that encode the bile acid 7α-dehydroxylation pathway.  
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 Bacterial species that harbor the 7α-dehydroxylation pathway are common in the 
mammalian gut. In fact, this activity has even been detected in bacterial isolates 
obtained from soil.93 Another possible explanation to the zebrafish’s lack of secondary 
bile metabolites is due to its oxygen exposure. The 7α-dehydroxylation pathway that is 
used to create secondary bile metabolites in most common in the species Clostridium, 
which belong to the Firmicutes phyla, require strictly anaerobic environments.91 
Zebrafish intestines experience higher oxygen exposure due to diffusion from the 
aqueous environment.76 We thought this host feature may allow for the discovery of 
unique bacterial species displaying novel bile metabolic pathways. Although, the lack of 
7α-dehydroxylation activity may also suggest that Clostridium species are not able to 
survive in the high oxygen levels within the zebrafish gut. Lan et al.94 examined the 
microbial diversity in the zebrafish intestine and found that while the zebrafish do 
possess Firmicutes, all species belong to Bacillus rather than Clostridium. Rawls et al.76 
showed that experiments where a conventional mouse microbiome was transplanted 
into germ-free zebrafish resulted in decreased Clostridium levels. Interestingly, a 
conventional zebrafish microbiome transplanted into a germ-free mouse showed 
amplification of Clostridium,76 which does support that Clostridium may persist in the 
adult zebrafish at low levels.  
 Disturbance of the endogenous microbiome and sampling are other possible 
explanations to the missing bile acid 7α-dehydroxylation activity. We aimed to culture 
fresh intestinal communities from 24 different zebrafish samples. Intestines were 
removed and the bacteria initially inoculated at Duke University, but we could not avoid 
the overnight transit time to get the cultures into our lab at the University of Illinois. It is 
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possible that some bacterial species lost viability during the dissection and/or the 
necessary transit. Additionally, all of our zebrafish were sacrificed at the same adult 
stage. Stephens et al.75 reports that the microbial population experiences drastic phyla 
shifts based on the age of the zebrafish. We could have possibly captured some bile 
acid 7α-dehydroxylation activity if we sampled fish from various ages, but this remains a 
speculation. Since we wanted to obtain broad species coverages, we incubated the 
microbial communities in both aerobic and anaerobic environments. Utilizing a 
microaerophilic growth condition could have also resulted in enhanced bacterial 
diversity and enzymatic activity.  
 In this set of experiments, we developed a robust LC/MS method that allowed us 
to examine bacterial bile acid and bile alcohol metabolism in a full scan untargeted 
mode. This was achieved after a lengthy 5αCS purification scheme and modified solid 
phase extraction protocol to recover the metabolites out of culture. We presented 
evidence that the zebrafish microbiome contains HSDHs and BSH enzymes, but it has 
not evolved to contain the bile acid/alcohol 7α-dehydroxylation pathway or sulfatase 
enzymes. Bacterial bile metabolites directly affect host physiology. The effects of 5αCS 
on host physiology and FXR regulation is worth investigating further, and it would be 
interesting to see if 5αCS has any other physiological function in the zebrafish other 
than dietary lipid absorption. This study can help fill the gap between other studies 
investigating how bile metabolites formed from the zebrafish microbiota potentially 
modulate host physiology and FXR expression in this popular animal model. 
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SUMMARY OF RESEARCH 
 
 The methods developed in this work support two seemingly different studies. 
However, these studies are linked by a common experimental design: end-product 
analysis of complex biological samples. LC/MS is the gold standard for achieving 
sample separation, sensitive detection levels, and mass data that can be used to 
identify compounds within a mixed biological sample.13 LC/MS can be used in 
untargeted mode for metabolite discovery. This approach allows for global compound 
detection, and it most often chosen when end-products or metabolites in the sample are 
unknown.1 LC/MS can also be used in a targeted analysis, where the expected 
metabolite is known and can be accurately quantified relative to a known internal 
standard.9 These are both incredibly robust strategies used when examining 
metabolomics and end-product analyses, however, LC/MS analysis is not a flawless 
approach. The greatest issue with LC/MS is its data reproducibility.8 In order to achieve 
standardization, LC/MS protocols must be generated and performed in-house on the 
same instrument with the same conditions.3 Indeed, this is what we accomplished 
throughout these studies; we successfully made our end-product analyses and 
conclusions using both targeted methods and untargeted LC/MS protocols.  
 The quantification of IMI levels in pig urine was accomplished through targeted 
LC/MS methodology.IMI is a neonicotinoid compound that is commonly applied to 
agricultural fields as a potent insecticide.27 It is a nicotine analog that is predicted to be 
specific to invertebrate nicotine acetylcholine receptors.37 However, this previously 
accepted claim is being challenged since levels of neonicotinoids have been recovered 
on mammalian food products,38 and they have been shown to alter mammalian immune 
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function.40 Production animals are also exposed to neonicotinoid contamination through 
their diet and their husbandry. Additionally, production animals are susceptible to viral 
infection outbreaks. Swine are at risk for PPRSV infection, which has devastating 
effects on production systems.49 The effects of neonicotinoid exposure on immune 
function during viral infection have not been previously studied, and our experiments 
contribute to the larger study investigating the detriments of IMI on pigs.43 
 In order to quantify IMI in urine, we needed to establish an SPE urine clean-up 
specific to IMI and the spiked internal standard D4-IMI. We determined that the absolute 
recovery of IMI after the SPE protocol was 92%. Then, we adopted an LC/MS method 
utilizing MRM mode, which enhanced instrument sensitivity and allowed us to quantify 
IMI by monitoring its fragmented daughter ions. Our work showed that IMI was 
recovered at an average level of 117.9 pg/ml in pig urine samples when the pigs were 
fed IMI, but we did not recover any imidacloprid in vehicle control urine. Our LOQ for 
this method was 50 fg/µl, and the LOD was 25 fg/µl. These parameters emphasize our 
method sensitivity, ensuring that even trace levels of IMI can be detected.  
 Our work investigating untargeted bile metabolite discovery in zebrafish was a 
more laborious study. We are collaborating with the Rawls Lab at Duke University, NC 
which is examining intestinal gene expression and cellular signaling in the zebrafish 
animal model.79,80 Specifically, they are interested in intestinal FXR signaling in relation 
to host physiology. Bile acids are known to regulate FXR signaling pathways.65 Bile 
acids also act as substrates to bacterial species in the gut, allowing for metabolized and 
modified bile species. Thus, these metabolites can also modulate FXR signaling,67 
which directly links the gut microbiome to these processes.  The Rawls laboratory 
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contacted us since we are well-versed in bacterial bile metabolism.64,68 While this is 
true, we did not have direct experience working with the zebrafish model, which has a 
distinctly different bile profile than mammals.50 Therefore, we began our investigation 
into zebrafish bile metabolism from the very beginning, which included identifying 
zebrafish biliary composition and obtaining appropriate standards.  
The first hurdle we experienced was obtaining the previously established 
zebrafish C27 bile alcohol, 5αCS, for experimental use since it cannot be commercially 
purchased.52,59 We attempted to reach out to other laboratories to obtain this standard, 
but we were unsuccessful. Therefore, we determined it was best to find a substantial 
source of crude bile and purify 5αCS ourselves. Using homogenized zebrafish would 
not provide an adequate amount for our intended experiments. Therefore, we sought 
out a local supermarket who sold Asian Carp, who are also known to produce 5αCS.55,59 
Through TLC extraction and column chromatography, we obtained pure 5αCS that we 
were able to verify on MS and NMR.  
Once we had our bile alcohol source, we wanted to determine the extent to which 
it is metabolized in carp and in zebrafish. In order to do this, we needed to generate an 
LC/MS method that allowed us to detect various bile metabolites. We worked with the 
University of Illinois School of Chemistry CORE mass spectrometry lab, and we were 
able to develop an untargeted LC/MS method that resolved a range of bile species 
including 5αCS, primary bile acid, bile acid conjugates, and secondary bile acids. Using 
this method, we were able to find a potentially epimerized form of 5αCS in the carp 
intestinal content. We were not able to analyze zebrafish intestines in the same manor, 
which led us to culturing intestinal dissections. We added in substrates 5αCS, TCA, and 
93 
 
ACA to test for metabolites that would be consistent with the presence of enzymes 
including sulfatases, HSDHs, BSHs, and the 7α-dehydroxylation pathway. We were 
able to detect likely HSDH and BSH activity in four biological replicate communities, 
which were grown both aerobically and anaerobically. While we did not detect 
desulfation or 7α-dehydroxylation, we detected a likely epimerization of 5αCS, which 
was similar to our observations in the carp sample. This was the first study that reported 
any metabolism of 5αCS.  
FUTURE RESEARCH 
 Both the targeted and untargeted LC/MS methods developed in these studies are 
useful for various experimental needs. The sensitive method we used for the 
quantification of IMI in pig urine can be used to investigate levels of other neonicotinoids 
in biological samples. However, our future work will mainly be focused on investigating 
the bile metabolism observed in zebrafish intestinal communities.  
 Our collaborators at Duke have sent us global lipid extraction from pools of 50 
whole zebrafish homogenates. We will be adapting our method to suit a targeted LC/MS 
strategy to quantify the amount of 5αCS in four different experimental groups. They 
have sent pools of wild type zebrafish as well as their fxr -/- transgenic zebrafish. Each of 
those two groups will be either germ-free or conventionalized. FXR is the master 
regulator of bile homeostasis and the gut microbiome modulates its signaling pathways 
in mice, causing increased levels of bile synthesis. 67 Therefore, we would expect the 
germ-free fxr -/- transgenic zebrafish to have the highest level of 5αCS when quantified.  
 We would like to identify the bacterial species responsible for the epimerization of 
5αCS. While our collaborators have investigated the zebrafish microbiome before, 74–76 
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the identity of specific species and strains that metabolize bile have not been 
investigated. Finding the bacterial species would then allow us to locate the HSDH 
enzyme. We would be able to purify this enzyme and characterize its activity, which our 
lab is equipped to do. These bacterial species possess HSDHs that recognize the 
hydroxyl group on either the C3, C7, or C12 position, but we do not know which hydroxyl 
group is being modified. If we can collect this purified epimerized compound on an LC 
fraction collector, then we would be able to obtain its structure using NMR 
spectroscopy.  
 Experiments that identify metabolites produced by the gut microbiome of rodents 
are reinforced by testing if these metabolites are present in germ-free conditions. 67,78 
Likewise, we would hope to test for bile acid and bile alcohol metabolites in a germ-free 
zebrafish. Our collaborators at Duke University are one of the few labs in the world 
capable of rearing a germ-free zebrafish. However, personal communications reveal 
that these germ-free zebrafish are not viable longer than approximately 2 weeks post-
fertilization, and the reason is unclear at this time. The zebrafish intestine does not 
develop epithelial folds ideal for harboring anaerobic bacteria until approximately 4 
weeks post-fertilization. Since we are interested in testing bacterial enzymes active in 
anaerobic conditions, the germ-free zebrafish may not be our ideal model. Examining 
metabolites after the administration of antibiotics used to decrease the bacterial load in 
the zebrafish microbiome is an option, but we will need to discuss this further with the 
Rawls Lab.  
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